{"meta":{"query_hash":"cf2946318e0f","filters":{"venue":"PharmacoEconomics & Outcomes News"},"cohort_total":104,"direct_labels_cover":1,"predictions_cover":104,"exported":104,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cf2946318e0f","api":"https://metacan.xera.ac/api/v1/cohort?venue=PharmacoEconomics+%26+Outcomes+News"},"results":[{"id":"W4205687154","doi":"10.2165/00151234-200605110-00026","title":"Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect,","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Quality of Life Research; Drug; Public administration; Business; Law; Public health; Political science; Medicine; Pharmacology","score_opus":0.05857380968842436,"score_gpt":0.3302997791268442,"score_spread":0.27172596943841987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205687154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9344884,0.00087841233,0.0005655377,0.05455002,0.001951651,0.0047841542,0.0023623942,0.000019998935,0.0003994317],"genre_scores_gemma":[0.9898988,0.000025473306,0.00021305529,0.007448673,0.00020034249,0.0004826052,0.00016297019,0.000062302264,0.0015057976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99382526,0.0004384551,0.0043322016,0.00064536923,0.0001982634,0.00056044623],"domain_scores_gemma":[0.9929893,0.0028570292,0.0030631183,0.0009004067,0.000040666022,0.00014947593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037342021,0.0004135323,0.0013138301,0.000065381886,0.0003708458,0.00011134193,0.0010327046,0.000084843836,0.0000783189],"category_scores_gemma":[0.00022705326,0.00028257558,0.00029094724,0.00014325736,0.00006048126,0.00040495567,0.00010665386,0.00029695767,0.000024004376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057696372,0.000096933574,0.8750877,0.00018847769,0.00017802864,9.083623e-8,0.0023466474,0.008227992,0.0000078045005,0.0009159467,0.11235407,0.00053865433],"study_design_scores_gemma":[0.009692699,0.00008384066,0.50336033,0.00022222387,0.00019774651,0.0000011058848,0.0019175808,0.025086911,0.0003854378,0.0020256473,0.45600846,0.0010180393],"about_ca_topic_score_codex":0.9864085,"about_ca_topic_score_gemma":0.9876821,"teacher_disagreement_score":0.37172735,"about_ca_system_score_codex":0.009761778,"about_ca_system_score_gemma":0.0009693821,"threshold_uncertainty_score":0.9999626},"labels":[],"label_agreement":null},{"id":"W4205914124","doi":"10.1007/bf03275801","title":"STD screening, treatment in Canada needs improving","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.04010359644339216,"score_gpt":0.36062402336956006,"score_spread":0.3205204269261679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205914124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263353,0.00013384793,0.00025222183,0.006685576,0.00035534296,0.0007529228,0.00004011785,0.000040437044,0.009106032],"genre_scores_gemma":[0.97624743,0.00017608512,0.0044303928,0.016522218,0.00008586219,0.000157062,0.000030452253,0.000041696352,0.0023087736],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851376,0.000039089013,0.0006562173,0.0003145374,0.00008829285,0.0003880806],"domain_scores_gemma":[0.9985825,0.0005553425,0.00015043956,0.00039187577,0.000023880908,0.00029599122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015614387,0.0002308575,0.00050580123,0.00011600272,0.00005467769,0.000021129608,0.0001304791,0.000050153154,0.000892632],"category_scores_gemma":[0.000115322444,0.0002071435,0.00013895554,0.00014720834,0.000024805213,0.00008645871,0.000022446477,0.00022255967,0.00008005486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029106048,0.00016265846,0.97800833,0.00001095554,0.00010769202,0.000007888363,0.00007851328,0.0001387121,0.00057915447,0.000582361,0.0020846534,0.018210001],"study_design_scores_gemma":[0.010226743,0.0001562713,0.22919132,0.00001415898,0.00028831407,0.00004036174,0.0009119598,0.0018406551,0.005315239,0.000313212,0.75110954,0.00059223425],"about_ca_topic_score_codex":0.76052105,"about_ca_topic_score_gemma":0.74478066,"teacher_disagreement_score":0.74902487,"about_ca_system_score_codex":0.0016653575,"about_ca_system_score_gemma":0.0014135833,"threshold_uncertainty_score":0.9773694},"labels":[],"label_agreement":null},{"id":"W4205978106","doi":"10.1007/bf03275954","title":"Nearly one-quarter market share for hep C prescriptions held by Roche's PEG IFN-α-2a","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medical prescription; Quality of Life Research; Medicine; Pharmacology; History; Public health","score_opus":0.0600780015680309,"score_gpt":0.44911276695689833,"score_spread":0.38903476538886744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205978106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4966445,0.0074009756,0.0036895387,0.16106732,0.02956477,0.02523193,0.014629382,0.002040336,0.25973123],"genre_scores_gemma":[0.63901526,0.0014243028,0.01048035,0.2217605,0.0019264019,0.005623944,0.000967483,0.0005264325,0.11827536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951209,0.0005992862,0.001531658,0.0008803317,0.00021462803,0.0016531975],"domain_scores_gemma":[0.99636495,0.0012642763,0.000564072,0.0007771428,0.00026710975,0.00076243025],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009685665,0.0005568735,0.0009476266,0.00016769586,0.0010582815,0.00008689735,0.0006036483,0.00037907608,0.009532363],"category_scores_gemma":[0.00036656752,0.0005874653,0.0003806727,0.00014537564,0.00005466506,0.0006126089,0.00013629276,0.00088472565,0.0031928653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014618265,0.00015589512,0.033672575,0.00039691385,0.00013221137,0.0000016997694,0.001098216,0.000006777545,0.00024378204,0.0013544562,0.96226394,0.0005273765],"study_design_scores_gemma":[0.0038236415,0.0001097565,0.006959291,0.00008303535,0.00012243754,0.0000025849602,0.0016635163,0.00037361734,0.00024461292,0.001206702,0.9848119,0.00059891556],"about_ca_topic_score_codex":0.001128518,"about_ca_topic_score_gemma":0.0012560167,"teacher_disagreement_score":0.14237073,"about_ca_system_score_codex":0.0008654002,"about_ca_system_score_gemma":0.0005108113,"threshold_uncertainty_score":0.9996577},"labels":[],"label_agreement":null},{"id":"W4206588241","doi":"10.1007/bf03269529","title":"Canadian recommendations on varicella zoster virus vaccine","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Varicella zoster virus; Chickenpox Vaccine; Quality of Life Research; Medicine; Varicella vaccine; Virus; Public health; Immunization; Immunology; Antibody","score_opus":0.027398837020450605,"score_gpt":0.3591745588026716,"score_spread":0.331775721782221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206588241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.761603,0.00007242153,0.000054499204,0.08016749,0.0016626788,0.0007239405,0.00013126372,0.00012820205,0.15545651],"genre_scores_gemma":[0.88818365,0.0011554,0.0005823335,0.09077506,0.00031318594,0.000088624554,0.00017208721,0.0000712583,0.018658387],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988151,0.000032120988,0.00036908788,0.00032065727,0.000056389013,0.00040660668],"domain_scores_gemma":[0.99887973,0.00009641378,0.000082431165,0.0003595791,0.000035658908,0.0005461579],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010235297,0.00024099092,0.00034956436,0.00034359522,0.0001995294,0.000049084778,0.00009314522,0.00007595055,0.008274222],"category_scores_gemma":[0.000014875346,0.00021614553,0.00017008292,0.00013841456,0.000007834649,0.00012045225,0.000023826813,0.00022773595,0.0039015096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021204869,0.0009392083,0.53920203,0.000013737765,0.0010604598,0.00022242912,0.00017944505,0.00009994254,0.00019183724,0.0006049254,0.16760935,0.28966457],"study_design_scores_gemma":[0.0029044223,0.00008000645,0.020055333,0.000009495578,0.00017546647,0.000060423983,0.000020463081,0.00022386131,0.00044762183,0.000077882774,0.9757519,0.00019315747],"about_ca_topic_score_codex":0.11001256,"about_ca_topic_score_gemma":0.14004372,"teacher_disagreement_score":0.8081425,"about_ca_system_score_codex":0.0008709218,"about_ca_system_score_gemma":0.0002023595,"threshold_uncertainty_score":0.9968741},"labels":[],"label_agreement":null},{"id":"W4206766375","doi":"10.2165/00151234-200404670-00020","title":"Benzodiazepines used for long periods among Canadian elderly","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Quality of Life Research; Public health; Medicine; Psychology; Pharmacology; Nursing","score_opus":0.04899817707140249,"score_gpt":0.4331009132495601,"score_spread":0.38410273617815766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206766375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947425,0.00013460273,0.00024148496,0.04434848,0.003458107,0.0023354467,0.00026991894,0.00014767639,0.0016392558],"genre_scores_gemma":[0.9414626,0.0001651216,0.0004945271,0.054742232,0.0009951426,0.00008428553,0.00013392026,0.00009285054,0.0018293463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717873,0.000094386414,0.0008822524,0.0004920984,0.000084645195,0.0012678931],"domain_scores_gemma":[0.99798685,0.00027062837,0.00030229133,0.00037851656,0.00007496399,0.0009867292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004339705,0.00034405282,0.00060267665,0.0002497649,0.0011555026,0.00004530536,0.00037268066,0.00019964173,0.0006535763],"category_scores_gemma":[0.00006679605,0.0003339646,0.00026961137,0.000093788294,0.00005030157,0.0003209876,0.000059657854,0.00060509006,0.00051160407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029427243,0.000059408576,0.97591263,0.00020799054,0.000067868306,0.0000048066036,0.0026175727,0.00017104308,0.000035909095,0.0017533865,0.01578324,0.003356734],"study_design_scores_gemma":[0.011045817,0.00010256704,0.6386037,0.00019573537,0.00010667187,0.0000029459413,0.001692721,0.00027060232,0.00012687153,0.00135057,0.34564242,0.0008593772],"about_ca_topic_score_codex":0.19866093,"about_ca_topic_score_gemma":0.7502843,"teacher_disagreement_score":0.55162334,"about_ca_system_score_codex":0.001151789,"about_ca_system_score_gemma":0.0018920064,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W4210414282","doi":"10.1007/s40274-021-08159-x","title":"Active TB screening may be cost saving in high-incidence Inuit communities in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Incidence (geometry); Public health; Environmental health; Medicine; Demography; Sociology; Mathematics; Nursing","score_opus":0.05181062410397016,"score_gpt":0.35541847498461887,"score_spread":0.30360785088064873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210414282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792843,0.00031394206,0.0000053367703,0.018241629,0.00030744274,0.00053107715,0.00019405918,0.000024581086,0.001097625],"genre_scores_gemma":[0.98562795,0.0011850307,0.00022275424,0.011941862,0.00010803107,0.000076743505,0.00014207025,0.00005094097,0.0006445936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754447,0.0001971044,0.000760046,0.00040921938,0.0003041258,0.00078501226],"domain_scores_gemma":[0.9980374,0.00088440184,0.00013913329,0.000530224,0.000105445055,0.0003034127],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003423835,0.00032505795,0.0008327799,0.0003033094,0.000100565645,0.00006865675,0.0003515138,0.000085575884,0.0014797655],"category_scores_gemma":[0.00017393783,0.00035726043,0.00012539887,0.00037286076,0.000060216735,0.00023431984,0.0003940225,0.0011011162,0.000024979914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043459522,0.00019353922,0.9456674,0.00011719016,0.00016985321,0.001265045,0.001888355,0.0018878855,0.0056836866,0.000089762834,0.0032188715,0.039383855],"study_design_scores_gemma":[0.016515592,0.00010323408,0.6767738,0.00057348347,0.00018046392,0.00022799925,0.04279073,0.010566451,0.1937343,0.000054653443,0.05702857,0.0014507335],"about_ca_topic_score_codex":0.95418227,"about_ca_topic_score_gemma":0.99320227,"teacher_disagreement_score":0.26889357,"about_ca_system_score_codex":0.004120359,"about_ca_system_score_gemma":0.0042471397,"threshold_uncertainty_score":0.99988794},"labels":[],"label_agreement":null},{"id":"W4210434457","doi":"10.1007/bf03275923","title":"US seniors retaliate against GSK over reduced drug supplies in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Drug; Environmental health; Business; Medicine; Pharmacology; Nursing","score_opus":0.02673352025819704,"score_gpt":0.2930338517553045,"score_spread":0.26630033149710747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210434457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92963636,0.00086950517,0.000005705007,0.007646137,0.0024069755,0.0004645359,0.0006183226,0.000042522675,0.058309942],"genre_scores_gemma":[0.94695705,0.0016516844,0.0001812377,0.049380213,0.00013386339,0.000068833,0.00004381783,0.00010205076,0.0014812521],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.995935,0.00006641295,0.001895711,0.0009310234,0.0000495393,0.0011222953],"domain_scores_gemma":[0.9980068,0.00021396716,0.00063822506,0.00061981706,0.000017523209,0.0005036183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006916742,0.00056180655,0.0012780749,0.00039722858,0.00013020022,0.00015297436,0.0006086795,0.0001096285,0.0022989884],"category_scores_gemma":[0.00009880281,0.0006943548,0.00031967415,0.00023541121,0.00006372432,0.00048941694,0.00012910947,0.00055232784,0.00085673155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047084242,0.00012462595,0.8811791,0.000048890197,0.00028553786,0.000032836182,0.00040325703,0.003104948,0.00015183788,0.064981766,0.04885511,0.00078500685],"study_design_scores_gemma":[0.0041710166,0.000010815378,0.05769782,0.000009997631,0.000027568363,0.0000072706393,0.00015251168,0.006414312,0.0017607202,0.011200801,0.9171717,0.0013754481],"about_ca_topic_score_codex":0.5327762,"about_ca_topic_score_gemma":0.5608751,"teacher_disagreement_score":0.8683166,"about_ca_system_score_codex":0.0019679146,"about_ca_system_score_gemma":0.0006815873,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4210470270","doi":"10.1007/bf03267359","title":"Canadian normative SF-36 data published","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Law, logistics, and international trade","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Normative; Political science; Public health; Law; Medicine","score_opus":0.05088517960913186,"score_gpt":0.3059408706275935,"score_spread":0.25505569101846165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210470270","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08569065,0.0001045725,0.000107968895,0.095147304,0.0037208525,0.00053853577,0.0005731357,0.00023877778,0.8138782],"genre_scores_gemma":[0.82569116,0.0001424476,0.00030301083,0.16065316,0.0027983624,0.00001974783,0.001367552,0.00005837536,0.008966205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984539,0.000009951662,0.00049287814,0.00045368134,0.00012598345,0.000463567],"domain_scores_gemma":[0.9990244,0.00006839461,0.00017778663,0.00057636935,0.00007192724,0.000081138285],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028387445,0.00024763515,0.0003052645,0.0002562935,0.00019574621,0.00091148954,0.0014332564,0.000058851987,0.019052982],"category_scores_gemma":[0.000089871166,0.00024412779,0.00009589279,0.000116398,0.000065384425,0.0043920963,0.00020044664,0.00019989355,0.0054560243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044481458,0.00008254192,0.07215783,0.000040380968,0.00023422105,0.00001817101,0.000092259754,0.00042547288,0.000008027398,0.030967392,0.8749041,0.021025104],"study_design_scores_gemma":[0.0007856566,0.0000020817617,0.009709367,0.0000044418675,0.000055512475,0.0000016221844,0.000044631535,0.018195672,0.000008116604,0.0033778811,0.9674946,0.0003203852],"about_ca_topic_score_codex":0.22207862,"about_ca_topic_score_gemma":0.13993487,"teacher_disagreement_score":0.804912,"about_ca_system_score_codex":0.00022359354,"about_ca_system_score_gemma":0.000120416946,"threshold_uncertainty_score":0.9955242},"labels":[],"label_agreement":null},{"id":"W4212981773","doi":"10.2165/00151234-201106410-00034","title":"Healthcare spending to reach > $200 billion in 2011 in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Health economics; Health spending; Public health; Economics; Business; Medicine; Economic growth; Health insurance; Nursing","score_opus":0.11026723973413086,"score_gpt":0.3291838321007124,"score_spread":0.21891659236658154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212981773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212936,0.0006842259,0.000091344926,0.047973003,0.0021483952,0.0010922935,0.00022814122,0.00003891939,0.026450058],"genre_scores_gemma":[0.9674393,0.00077525247,0.0006437733,0.030321233,0.00008952667,0.00011005217,0.000015316322,0.000049440358,0.0005561074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996867,0.00004994805,0.0014624936,0.00069595466,0.0000407598,0.0008838487],"domain_scores_gemma":[0.99876225,0.00006717176,0.0003182628,0.00045539418,0.000011503298,0.0003854376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007912067,0.0002964249,0.0007702377,0.0008673274,0.000058122547,0.00003015872,0.00048517756,0.000078442936,0.0010993613],"category_scores_gemma":[0.000039772873,0.0003694229,0.000095407006,0.00025992814,0.000011506598,0.00029919363,0.00017480474,0.00032428268,0.0011613736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004070533,0.000065917484,0.92506295,0.000064753134,0.000026533935,0.00003272254,0.0012222038,0.00014082575,0.0000028126997,0.06266996,0.0053583663,0.00531222],"study_design_scores_gemma":[0.0017389889,0.00005256264,0.6673359,0.000028997581,0.000004965026,0.000003297274,0.0005097536,0.0010358106,0.000101511236,0.008935553,0.31946245,0.0007901807],"about_ca_topic_score_codex":0.99233174,"about_ca_topic_score_gemma":0.98725325,"teacher_disagreement_score":0.31410408,"about_ca_system_score_codex":0.0030004594,"about_ca_system_score_gemma":0.0002979169,"threshold_uncertainty_score":0.9998758},"labels":[],"label_agreement":null},{"id":"W4213052584","doi":"10.1007/bf03278651","title":"Best case needed to see oseltamivir value for 'flu in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oseltamivir; Quality of Life Research; Value (mathematics); Medicine; Public health; Coronavirus disease 2019 (COVID-19); Mathematics; Statistics; Internal medicine","score_opus":0.04731400848501163,"score_gpt":0.34058062178501364,"score_spread":0.29326661330000203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213052584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637511,0.00029705238,0.000034779598,0.029070806,0.00095924304,0.00150358,0.00024627076,0.000040848856,0.004096335],"genre_scores_gemma":[0.9115418,0.0002771289,0.0013364289,0.08343844,0.00022623582,0.00028685722,0.000011429842,0.000069191185,0.0028124538],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981271,0.000034294728,0.0006651037,0.0004335521,0.000107234475,0.00063272903],"domain_scores_gemma":[0.99872905,0.0003719859,0.000104299455,0.00033264802,0.00005330798,0.00040872014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001541832,0.00031766147,0.0007710983,0.00019152345,0.000113313705,0.000025475389,0.00015397591,0.000049895072,0.000451366],"category_scores_gemma":[0.00016141513,0.0003233064,0.00014465145,0.00013869036,0.000020277688,0.000118211225,0.000098877455,0.00020856886,0.0003578357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012410818,0.00025282806,0.5727821,0.00015861774,0.000394901,0.0017237054,0.0018487629,0.0007985189,0.0007120005,0.00016418897,0.39706844,0.023971828],"study_design_scores_gemma":[0.012713416,0.0002840497,0.017856041,0.00007626805,0.0004644869,0.0006764228,0.0020939724,0.02157054,0.0034916876,0.00005425351,0.9394906,0.0012282738],"about_ca_topic_score_codex":0.9681303,"about_ca_topic_score_gemma":0.9887216,"teacher_disagreement_score":0.55492604,"about_ca_system_score_codex":0.0017374897,"about_ca_system_score_gemma":0.0003469786,"threshold_uncertainty_score":0.9999219},"labels":[],"label_agreement":null},{"id":"W4213146317","doi":"10.1007/bf03279452","title":"Effect of H2-antagonist Rx-to-OTC switch in the US, UK and Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Public health","score_opus":0.011070616997440103,"score_gpt":0.3012965126590904,"score_spread":0.2902258956616503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213146317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837249,0.0004027084,0.0000037864909,0.010936272,0.0003422379,0.0007369959,0.0000246497,0.00001208436,0.0038163587],"genre_scores_gemma":[0.974882,0.0003297594,0.00006864431,0.024007099,0.00012192715,0.00004066562,0.000005246175,0.00002399716,0.0005206316],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880224,0.00011105485,0.00039465402,0.00025067915,0.00012540407,0.0003159651],"domain_scores_gemma":[0.9985835,0.00083494245,0.000096715194,0.0003029395,0.000013571302,0.00016832912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045508347,0.00022075027,0.0005825798,0.0001096115,0.000046696434,0.00002052009,0.00018377276,0.000042483876,0.00024745212],"category_scores_gemma":[0.0000873884,0.00014930399,0.00009201234,0.00010242201,0.000028864519,0.000045937726,0.00005028825,0.00022960275,0.000043820794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025871137,0.000068359375,0.9320974,0.00021336706,0.00012927204,0.00009972101,0.0003338119,0.00007017126,0.0031559237,0.000035285688,0.044749904,0.018788079],"study_design_scores_gemma":[0.039635807,0.0021210534,0.2922616,0.0002035843,0.0014701441,0.00053386233,0.0004838866,0.0050219735,0.08605773,0.000095246534,0.57051027,0.0016048736],"about_ca_topic_score_codex":0.30166417,"about_ca_topic_score_gemma":0.15626821,"teacher_disagreement_score":0.6398358,"about_ca_system_score_codex":0.00014636727,"about_ca_system_score_gemma":0.00006960966,"threshold_uncertainty_score":0.8591277},"labels":[],"label_agreement":null},{"id":"W4229933154","doi":"10.2165/00151234-200705310-00009","title":"High intensity use of proton pump inhibitors (PPIs) increased between 1997 and 2004 in Canada,","year":2007,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Intensity (physics); Medicine; Public health; Optics; Physics","score_opus":0.02376855002883469,"score_gpt":0.3031655579418374,"score_spread":0.2793970079130027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229933154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977947,0.000035358993,0.0000068856493,0.0007178484,0.0002073203,0.0010109534,0.00015738017,0.000016634596,0.000052957927],"genre_scores_gemma":[0.9964482,0.00003274597,0.0004527675,0.002736756,0.000086720815,0.000018139639,0.00010375568,0.000027872402,0.00009302371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984615,0.00002710547,0.0006758881,0.00031024867,0.0001310471,0.00039423537],"domain_scores_gemma":[0.99895287,0.00019855348,0.00021684701,0.00022266804,0.000045503566,0.00036358438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002286636,0.00025177395,0.00076750695,0.00018679474,0.000030722,0.000012811764,0.0000749275,0.000061338695,0.00004892723],"category_scores_gemma":[0.000058442416,0.00022263928,0.000075391006,0.00008768545,0.000044406213,0.00017029396,0.00007336789,0.00023384302,0.000008562113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021012647,0.00008855852,0.9949897,0.00005908501,0.00017675998,0.0002176921,0.00004945063,0.0000078442845,0.0002411851,0.000006041692,0.00064775685,0.0033058133],"study_design_scores_gemma":[0.0045151296,0.00008423327,0.95837474,0.000022617833,0.00014631236,0.000013097376,0.000032279786,0.00003145179,0.035439797,0.00002058821,0.0012174211,0.00010232359],"about_ca_topic_score_codex":0.79244673,"about_ca_topic_score_gemma":0.32600927,"teacher_disagreement_score":0.46643746,"about_ca_system_score_codex":0.0008019748,"about_ca_system_score_gemma":0.00041263297,"threshold_uncertainty_score":0.90789664},"labels":[],"label_agreement":null},{"id":"W4230020078","doi":"10.1007/bf03280012","title":"Universal healthcare sustainable in Canada?","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Public health; Health economics; Health administration; Business; Economics; Medicine; Nursing; Economic growth","score_opus":0.03102327070289286,"score_gpt":0.3012074803041892,"score_spread":0.27018420960129635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230020078","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3871832,0.00021000448,0.000004875135,0.5610058,0.0010747323,0.0003722755,0.000009651235,0.00006368057,0.05007579],"genre_scores_gemma":[0.6297313,0.00014180935,0.00001794744,0.3686266,0.00037529826,0.000012617379,0.000009968143,0.000018943087,0.001065545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804157,0.000027114676,0.0005353491,0.00029452099,0.000072465795,0.001028964],"domain_scores_gemma":[0.9993391,0.00010268703,0.00021875526,0.00020874088,0.000058301277,0.00007239786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030408413,0.00020302125,0.00043720723,0.00021840674,0.00013467953,0.00007001315,0.00034433862,0.00005390489,0.0010945093],"category_scores_gemma":[0.000094109586,0.00020681125,0.00006863809,0.00023858956,0.000019724657,0.00076086645,0.00019403924,0.00023597664,0.00033999232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000074082764,0.000019284611,0.20830733,0.00010154115,0.000012001358,0.000031386397,0.00001757281,0.0015449119,4.2294164e-7,0.04456583,0.7437314,0.0016609334],"study_design_scores_gemma":[0.0007742628,0.0000025896175,0.014688586,0.0000029306996,0.000007082453,0.000001337459,0.0010212107,0.026953312,3.0619873e-7,0.0006532371,0.95569986,0.0001952587],"about_ca_topic_score_codex":0.99648887,"about_ca_topic_score_gemma":0.94926614,"teacher_disagreement_score":0.24254808,"about_ca_system_score_codex":0.001387337,"about_ca_system_score_gemma":0.00027876673,"threshold_uncertainty_score":0.9998186},"labels":[],"label_agreement":null},{"id":"W4230031586","doi":"10.1007/bf03267249","title":"Propentofylline worth it in Canada's AD population","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.01827595898962494,"score_gpt":0.3298364210698375,"score_spread":0.3115604620802126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230031586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671202,0.00021531481,0.0000011328685,0.026795967,0.00031617522,0.0006682345,0.00002427462,0.00003168576,0.004827044],"genre_scores_gemma":[0.95167994,0.0007280327,0.00017889969,0.04071745,0.00006948376,0.00005320127,0.00012322486,0.000023525872,0.0064262217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986918,0.000045517514,0.00048532593,0.00032071068,0.000094448704,0.00036220378],"domain_scores_gemma":[0.99943167,0.00005306836,0.00008251678,0.0001974297,0.000014557591,0.00022074954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000108090346,0.0002189115,0.0004719122,0.00009327181,0.000055774017,0.0000112861335,0.00011697415,0.000048793056,0.006876098],"category_scores_gemma":[0.0000069568,0.00019835393,0.00009117238,0.00008574485,0.000013689063,0.0001347604,0.000023505296,0.00023954258,0.00030827135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003518886,0.00025236903,0.93651074,0.000021521955,0.00013644173,0.00014852184,0.00007018467,0.00055292464,0.000098923716,0.000010087598,0.011346272,0.0505001],"study_design_scores_gemma":[0.005596077,0.00003884063,0.85223323,0.000015616215,0.0001583952,0.000026062702,0.00002877821,0.0018435398,0.0005383924,0.00003498112,0.13926592,0.00022016875],"about_ca_topic_score_codex":0.62848705,"about_ca_topic_score_gemma":0.8728157,"teacher_disagreement_score":0.2443287,"about_ca_system_score_codex":0.0013572081,"about_ca_system_score_gemma":0.0005511599,"threshold_uncertainty_score":0.9940317},"labels":[],"label_agreement":null},{"id":"W4230081928","doi":"10.1007/bf03280326","title":"Sumatriptan nearly always cost saving for Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Sumatriptan; Business; Economics; Public health; Medicine","score_opus":0.02529442409879043,"score_gpt":0.32867776140831495,"score_spread":0.3033833373095245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230081928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87398714,0.00071015075,0.00039998232,0.061382283,0.0027397727,0.0026352687,0.00012975522,0.00021534813,0.057800278],"genre_scores_gemma":[0.8720954,0.00089144404,0.0014718238,0.096009225,0.0010245077,0.00023780072,0.00015946242,0.00015626397,0.027954053],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804497,0.000040423238,0.00063708494,0.0004325948,0.00018551218,0.0006594392],"domain_scores_gemma":[0.9979669,0.0008769025,0.00015609768,0.00038514103,0.000091539594,0.000523433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030647006,0.00034473158,0.00118293,0.00010281901,0.00015492359,0.0000754221,0.00020157236,0.000089549474,0.00053997786],"category_scores_gemma":[0.00012987685,0.00030985463,0.00063353666,0.0001265821,0.000035542987,0.0001629882,0.00004389181,0.0002175102,0.00007634822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004910229,0.00008452399,0.897668,0.00006792491,0.00046653757,0.0002491691,0.00009535757,0.00007985373,0.0003355431,0.0020913966,0.06940248,0.028968165],"study_design_scores_gemma":[0.003911439,0.00003749561,0.08230335,0.000009544751,0.00021439299,0.00015731763,0.00012552991,0.0004242098,0.00020719039,0.00001627944,0.91226566,0.00032759493],"about_ca_topic_score_codex":0.12628652,"about_ca_topic_score_gemma":0.10963957,"teacher_disagreement_score":0.84286314,"about_ca_system_score_codex":0.00061312725,"about_ca_system_score_gemma":0.0006898371,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W4230202677","doi":"10.1007/s40274-014-1349-2","title":"Guanfacine's stimulating results in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Animal Nutrition and Physiology","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guanfacine; Quality of Life Research; Economics; Medicine; Public health; Anesthesia; Clonidine","score_opus":0.02343419157195818,"score_gpt":0.27642799691090236,"score_spread":0.25299380533894417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230202677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821793,0.000015259264,8.7381284e-7,0.014279328,0.00021979863,0.00010196488,0.00007195422,0.000021184569,0.0031103326],"genre_scores_gemma":[0.98186094,0.00002324771,0.000053690506,0.017726459,0.00015990654,0.000006187446,0.000058621787,9.859914e-7,0.000109974295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903584,0.00006867896,0.00034914847,0.00024274646,0.000045931767,0.000257665],"domain_scores_gemma":[0.9993225,0.00042791924,0.000095670155,0.00004254555,0.000013266227,0.00009810828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012695948,0.00012382021,0.0002402312,0.00000944706,0.0000610685,0.000017348384,0.00018519006,0.000030654468,0.00038139345],"category_scores_gemma":[0.000039256138,0.000055813227,0.00005520662,0.000067220615,0.000010501097,0.000072379764,0.00004850418,0.00011791519,0.000055601096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034424575,0.00010482274,0.6913594,0.00001274073,0.000031099244,0.0000072885528,0.000070948256,0.0023002229,0.11818133,0.0010492863,0.035335008,0.15120357],"study_design_scores_gemma":[0.0011505879,0.0000690959,0.7623329,0.000004955383,0.000004685919,0.0000014128824,0.00011693418,0.006257662,0.0003474921,0.00047561913,0.2289769,0.00026171864],"about_ca_topic_score_codex":0.7727603,"about_ca_topic_score_gemma":0.94114166,"teacher_disagreement_score":0.19364189,"about_ca_system_score_codex":0.00012970163,"about_ca_system_score_gemma":0.00002935429,"threshold_uncertainty_score":0.41759908},"labels":[],"label_agreement":null},{"id":"W4230377058","doi":"10.1007/bf03275770","title":"Paracetamol vs NSAID prescribing among the elderly in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Health economics; Public health; Nursing","score_opus":0.013351717169690816,"score_gpt":0.2757582234878619,"score_spread":0.2624065063181711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230377058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966575,0.00027918932,0.000009226364,0.0033696673,0.001395795,0.00087318325,0.0000071685986,0.000029744288,0.0043702573],"genre_scores_gemma":[0.9874598,0.00011068516,0.00006783739,0.01138018,0.00014001929,0.0000922422,0.0000061346154,0.00004467913,0.0006984321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982338,0.00015429515,0.0005600051,0.00033063078,0.00015875974,0.0005624873],"domain_scores_gemma":[0.9987901,0.00033696977,0.00016750018,0.00041483567,0.000025556887,0.00026503977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049427577,0.00028476276,0.0005543824,0.00008982146,0.00010022678,0.000034889075,0.00019899532,0.00005994775,0.00040802488],"category_scores_gemma":[0.00013005505,0.00021022173,0.00014081485,0.00010329149,0.000041364925,0.00016452545,0.000034161243,0.0004650504,0.00007297324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007456492,0.000032533513,0.98138136,0.00004961544,0.0000905016,0.0001183289,0.00020657488,0.00029923525,0.00025062577,0.00020994071,0.013784501,0.0035022227],"study_design_scores_gemma":[0.009786621,0.00016170972,0.65521306,0.00008476354,0.0002888533,0.00008719636,0.00076575775,0.0042303493,0.017437808,0.000128797,0.31094363,0.0008714511],"about_ca_topic_score_codex":0.47776192,"about_ca_topic_score_gemma":0.7294532,"teacher_disagreement_score":0.3261683,"about_ca_system_score_codex":0.00075872376,"about_ca_system_score_gemma":0.0011728165,"threshold_uncertainty_score":0.8572593},"labels":[],"label_agreement":null},{"id":"W4230555985","doi":"10.2165/00151234-200605140-00024","title":"Isotretinoin use inappropriate in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Isotretinoin; Quality of Life Research; Medicine; Dermatology; Public health; Nursing","score_opus":0.01338503712542532,"score_gpt":0.2821876621866829,"score_spread":0.26880262506125757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230555985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990095,0.00014603128,0.000008879082,0.0059021795,0.0003887696,0.00037936878,0.000024760007,0.000025001917,0.003029994],"genre_scores_gemma":[0.9848611,0.00012806043,0.00029315084,0.011195468,0.00012322848,0.000024636774,0.000059201102,0.00002823697,0.0032869172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892414,0.00002504876,0.00036190022,0.00026127422,0.00007478099,0.00035285065],"domain_scores_gemma":[0.999491,0.000083762156,0.0000877482,0.00019767795,0.000014209254,0.0001256173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006338349,0.00020754793,0.00043169077,0.00008147002,0.000042936936,0.00002646723,0.00006945289,0.00004099929,0.00021298678],"category_scores_gemma":[0.000009492343,0.00016307374,0.00009597736,0.0000676418,0.000012754386,0.00013854008,0.00003719017,0.00015367026,0.00006644437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008168442,0.00010892701,0.9641645,0.000024145324,0.000059738504,0.000171699,0.000024249393,0.00026249452,0.0002662742,0.00007018789,0.032033525,0.002732583],"study_design_scores_gemma":[0.0066870777,0.00004690437,0.8558129,0.000022401726,0.00012163761,0.00002864211,0.00006531332,0.0021892907,0.0020744954,0.00008620372,0.13254441,0.00032068437],"about_ca_topic_score_codex":0.95512635,"about_ca_topic_score_gemma":0.87715966,"teacher_disagreement_score":0.10835156,"about_ca_system_score_codex":0.0007263057,"about_ca_system_score_gemma":0.0005171371,"threshold_uncertainty_score":0.6649954},"labels":[],"label_agreement":null},{"id":"W4230561190","doi":"10.2165/00151234-201006090-00003","title":"Grade A NACI recommendation for rotavirus vaccine in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Rotavirus vaccine; Rotavirus; Virology; Medicine; Public health; Virus; Nursing","score_opus":0.03283751322459917,"score_gpt":0.3880215328744271,"score_spread":0.35518401964982793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230561190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152787,0.000018645305,0.0001017195,0.08254968,0.00093461503,0.0007277204,0.00010214307,0.00001788364,0.00026890787],"genre_scores_gemma":[0.9643418,0.00018870275,0.0020301803,0.032538127,0.00023672842,0.00018074398,0.0001926482,0.000028814275,0.00026226116],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855524,0.00004631218,0.0005288367,0.0002909613,0.000048722988,0.0005299086],"domain_scores_gemma":[0.99926543,0.000120219825,0.00010728803,0.00018413368,0.000031278636,0.00029166686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003328691,0.00016427544,0.00050995406,0.00012114224,0.00004106871,0.000012647973,0.00013732044,0.000048945214,0.0007372115],"category_scores_gemma":[0.0002299954,0.000153865,0.00010959976,0.000048831378,0.0000114154545,0.00011612935,0.000048919523,0.0004326884,0.000026617816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005063586,0.00007550728,0.8722718,0.00004061368,0.00007030707,0.000014721655,0.000017021734,0.000023617225,0.012058404,0.00006461409,0.073661916,0.041195124],"study_design_scores_gemma":[0.012347946,0.00019896583,0.36516833,0.000011710089,0.000041826253,0.000074518306,0.00008192028,0.0099414615,0.0018580541,0.00030776576,0.6097069,0.00026064683],"about_ca_topic_score_codex":0.6103785,"about_ca_topic_score_gemma":0.95389336,"teacher_disagreement_score":0.53604496,"about_ca_system_score_codex":0.00045603665,"about_ca_system_score_gemma":0.00047731076,"threshold_uncertainty_score":0.8071949},"labels":[],"label_agreement":null},{"id":"W4230928897","doi":"10.1007/s40274-013-0659-0","title":"Self-injectable SC abatacept available in Canada for RA","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Quality of Life Research; Medicine; Public health; Internal medicine; Nursing","score_opus":0.018339566568218123,"score_gpt":0.28105739096763044,"score_spread":0.2627178243994123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230928897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811258,0.0028334302,0.000008846521,0.004792926,0.0013005052,0.0021447858,0.00007021423,0.000082900224,0.007640635],"genre_scores_gemma":[0.96715724,0.0018764946,0.0012540921,0.019712407,0.00028361555,0.00028860618,0.000072179755,0.00008799969,0.00926738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827796,0.000028496925,0.0006508188,0.00039801965,0.00010742701,0.0005373007],"domain_scores_gemma":[0.99890524,0.00018196124,0.00016575093,0.00032824738,0.00006562389,0.00035315726],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014237482,0.00025406186,0.0006291511,0.00011892679,0.00006682048,0.000050874194,0.00018020243,0.00007458847,0.004159644],"category_scores_gemma":[0.000041540447,0.00021624588,0.000173642,0.00009705966,0.000012749568,0.00022942234,0.000047412697,0.00016658318,0.0010003857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065873086,0.00015094316,0.38396707,0.00018522046,0.0003069441,0.0000067026203,0.0001269645,0.00014160568,0.0013724641,0.000024454692,0.6106007,0.003051036],"study_design_scores_gemma":[0.036480285,0.00020020167,0.16014715,0.00048296593,0.0010252703,0.000083204766,0.0036829656,0.05847553,0.011443326,0.00014849321,0.7259695,0.0018610972],"about_ca_topic_score_codex":0.78365684,"about_ca_topic_score_gemma":0.21312626,"teacher_disagreement_score":0.5705306,"about_ca_system_score_codex":0.0011722376,"about_ca_system_score_gemma":0.0015184176,"threshold_uncertainty_score":0.99977744},"labels":[],"label_agreement":null},{"id":"W4230978315","doi":"10.1007/bf03280259","title":"Prescription drug spending in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medical prescription; Drug; Prescription drug; Health economics; Public health; Business; Public economics; Economics; Medicine; Pharmacology; Nursing","score_opus":0.05390289870986077,"score_gpt":0.31511780977051973,"score_spread":0.26121491106065897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230978315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9016051,0.00057630363,0.00018840593,0.04157542,0.0023640676,0.000509635,0.000101143945,0.000043803328,0.0530361],"genre_scores_gemma":[0.9761699,0.0013029671,0.0001560864,0.019336337,0.00012433573,0.000049829265,0.00001614727,0.000032356795,0.0028120778],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979572,0.00002548381,0.00096016505,0.00045154386,0.00003077566,0.00057478633],"domain_scores_gemma":[0.99914604,0.00006446011,0.0002925796,0.00030514743,0.0000065709305,0.00018520576],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043397854,0.00021111287,0.00049220107,0.0002973586,0.000071083465,0.00005989342,0.00032756783,0.00003528446,0.00111488],"category_scores_gemma":[0.000030911127,0.00026894023,0.00009443269,0.00014834311,0.0000109124585,0.00038092787,0.00010094952,0.00021417651,0.00066303246],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016339265,0.000036223264,0.9166603,0.000028206043,0.00004072812,0.000022717324,0.00021422103,0.0007066851,0.0000034611146,0.061840385,0.015915899,0.004514817],"study_design_scores_gemma":[0.0010828824,0.0000053509443,0.17764203,0.0000065842855,0.0000045141114,0.000003376679,0.00017420221,0.00408923,0.000029409886,0.00580214,0.81081176,0.0003485449],"about_ca_topic_score_codex":0.9853306,"about_ca_topic_score_gemma":0.97770697,"teacher_disagreement_score":0.7948958,"about_ca_system_score_codex":0.0019343387,"about_ca_system_score_gemma":0.000151592,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W4231037796","doi":"10.1007/s40274-017-4376-y","title":"Addition of palbociclib to letrozole not cost effective in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Letrozole; Quality of Life Research; Medicine; Public health; Internal medicine; Cancer; Breast cancer","score_opus":0.019636002678375175,"score_gpt":0.3615838674096126,"score_spread":0.34194786473123745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231037796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98291916,0.000053365107,0.00008355602,0.013102868,0.0006915862,0.0014322088,0.00026520653,0.000015847705,0.0014361945],"genre_scores_gemma":[0.9835968,0.000034116372,0.00043472418,0.015273453,0.00013074717,0.0002618617,0.000019751737,0.000033265387,0.00021526446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989159,0.000025381412,0.00037561147,0.0002788842,0.00010537056,0.00029883214],"domain_scores_gemma":[0.9988448,0.00015986993,0.00028385114,0.00047354237,0.000044528035,0.0001934219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011045319,0.0001900393,0.00057016034,0.00010000088,0.000071456896,0.000016996928,0.00024179326,0.00003094761,0.00032463574],"category_scores_gemma":[0.000083409934,0.00018928545,0.00008961616,0.000035604695,0.00004048243,0.00021170253,0.000086629494,0.00017952715,0.000039597966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012533326,0.000078967954,0.6835611,0.00008062492,0.00021235523,0.000035784567,0.0002753883,0.00080948236,0.011588238,0.00010760796,0.003343477,0.29865366],"study_design_scores_gemma":[0.0064808144,0.00006160827,0.8320439,0.00006214498,0.000054333294,0.000008953841,0.00016813715,0.00034149227,0.05411708,0.000064216525,0.106347926,0.0002494036],"about_ca_topic_score_codex":0.5895726,"about_ca_topic_score_gemma":0.75359654,"teacher_disagreement_score":0.29840428,"about_ca_system_score_codex":0.001423251,"about_ca_system_score_gemma":0.00048646823,"threshold_uncertainty_score":0.7718836},"labels":[],"label_agreement":null},{"id":"W4231445442","doi":"10.1007/bf03269629","title":"Canadian primary healthcare initiatives target of funding","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Primary care; Business; Health economics; Health care; Public health; Medicine; Nursing; Economics; Economic growth; Family medicine","score_opus":0.08296956919041963,"score_gpt":0.45379982231416943,"score_spread":0.3708302531237498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231445442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46039826,0.0019614655,0.00012177257,0.21863842,0.0058171065,0.0022630699,0.0007633685,0.00025911687,0.3097774],"genre_scores_gemma":[0.5783062,0.003502221,0.0015331398,0.41095054,0.00065066374,0.00017489228,0.0002327941,0.00010514865,0.004544406],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595255,0.00044751778,0.0015207989,0.0004698349,0.00016800062,0.0014413047],"domain_scores_gemma":[0.9967454,0.0009340795,0.0006609909,0.0005020514,0.00017062113,0.0009868522],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008392649,0.00037279833,0.0010673517,0.00055228325,0.0007792366,0.000013910549,0.0005166863,0.00024801126,0.0036696643],"category_scores_gemma":[0.00009040672,0.0003682306,0.00025286188,0.00024493187,0.000055692664,0.00058504357,0.00018108005,0.0009074325,0.0007046969],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007432267,0.000031754244,0.9385004,0.00038395572,0.00009918042,0.000018729086,0.0018123396,0.000010079845,0.00005231379,0.0028485954,0.052826166,0.0033421395],"study_design_scores_gemma":[0.0018434734,0.00004880494,0.33743843,0.00004112302,0.000039821778,0.000004526548,0.0013946698,0.00003766013,0.00004044441,0.0012608195,0.6574559,0.00039430242],"about_ca_topic_score_codex":0.17170331,"about_ca_topic_score_gemma":0.20140761,"teacher_disagreement_score":0.60462976,"about_ca_system_score_codex":0.0037367463,"about_ca_system_score_gemma":0.006260414,"threshold_uncertainty_score":0.999877},"labels":[],"label_agreement":null},{"id":"W4231931420","doi":"10.1007/bf03277078","title":"Cautions over Canadian Rx imports, prices substantially lower","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Agricultural Economics and Policy","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Public health; Medicine","score_opus":0.016877721643222102,"score_gpt":0.2708490735879757,"score_spread":0.2539713519447536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231931420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649515,0.000168837,7.160909e-7,0.009531259,0.0009814744,0.00029194745,0.00026465222,0.000058448113,0.023751166],"genre_scores_gemma":[0.9820632,0.000383081,0.00007173565,0.015262124,0.00032281573,0.00002258087,0.00009856212,0.0000036465033,0.0017722978],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983628,0.00003781423,0.00045895958,0.00041145622,0.00006096964,0.00066800416],"domain_scores_gemma":[0.9989843,0.00011138074,0.000187819,0.0000997509,0.000029449162,0.00058733515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018333584,0.00029297904,0.0003321868,0.00003395833,0.0003551735,0.0001900809,0.00034687275,0.00011563541,0.005985559],"category_scores_gemma":[0.00001595094,0.00012751034,0.00026400998,0.00015222841,0.000037613907,0.00032798146,0.000037673923,0.00017933612,0.00043736666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004231019,0.00031293824,0.6636993,0.000014252081,0.0004496732,0.000055369248,0.00037221718,0.00025107234,0.024051245,0.082623124,0.2011025,0.027025962],"study_design_scores_gemma":[0.00023590658,0.000026412301,0.16753668,0.0000016836793,0.000025291589,0.000010772205,0.000070780035,0.00004342378,0.0003032009,0.00055274257,0.8308093,0.00038378153],"about_ca_topic_score_codex":0.1514046,"about_ca_topic_score_gemma":0.58590674,"teacher_disagreement_score":0.6297068,"about_ca_system_score_codex":0.0002465008,"about_ca_system_score_gemma":0.0001019569,"threshold_uncertainty_score":0.9949231},"labels":[],"label_agreement":null},{"id":"W4232189755","doi":"10.2165/00151234-200604940-00026","title":"Lost productivity drives schizophrenia burden in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Productivity; Schizophrenia (object-oriented programming); Public health; Economics; Psychiatry; Business; Public economics; Medicine; Economic growth","score_opus":0.11681680249891628,"score_gpt":0.39537867890253353,"score_spread":0.27856187640361724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232189755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87242246,0.001182414,0.00012333394,0.11326314,0.0019672017,0.0009807647,0.0004958988,0.000054643955,0.009510154],"genre_scores_gemma":[0.9732218,0.000119634286,0.0013055332,0.021841645,0.001141519,0.00012842026,0.00007340933,0.00008685009,0.002081211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928098,0.00025996682,0.0048461547,0.0011023923,0.00010216754,0.00087953365],"domain_scores_gemma":[0.9960959,0.0007862866,0.0020540783,0.00076390215,0.00004004218,0.0002597709],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0042563817,0.00045683127,0.0016977111,0.0004650785,0.0001562477,0.00012796045,0.0006267,0.00011139041,0.0011770787],"category_scores_gemma":[0.0005449657,0.00060695293,0.00019618751,0.00022642099,0.00006148444,0.00090893044,0.00013404344,0.0004034144,0.00264752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037318354,0.0000991129,0.88287115,0.0001228407,0.00008514392,0.0000072440303,0.00025453127,0.0052446183,0.000023538983,0.022972476,0.087754354,0.0005276526],"study_design_scores_gemma":[0.0045815688,0.00002609736,0.59070075,0.000037806716,0.000019733547,0.000011499225,0.00061420805,0.00997894,0.00013180333,0.019502044,0.37295052,0.0014450692],"about_ca_topic_score_codex":0.94972396,"about_ca_topic_score_gemma":0.9402434,"teacher_disagreement_score":0.29217046,"about_ca_system_score_codex":0.004253753,"about_ca_system_score_gemma":0.0014093919,"threshold_uncertainty_score":0.99973595},"labels":[],"label_agreement":null},{"id":"W4232246152","doi":"10.1007/s40274-016-2750-9","title":"Analysing high-cost users of healthcare in Canada","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Business; Health care; Public health; Health administration; Computer science; Nursing; Medicine; Economics; Economic growth","score_opus":0.05158430184563264,"score_gpt":0.3235502121192386,"score_spread":0.271965910273606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232246152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7975903,0.00042828097,0.000455142,0.19672088,0.0012503938,0.0005382243,0.000740568,0.000023652125,0.0022525368],"genre_scores_gemma":[0.9797786,0.00087169406,0.00023748558,0.0186444,0.000067091765,0.000039733073,0.000009838089,0.00003141364,0.00031978427],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975107,0.000039118393,0.0013812131,0.00046234415,0.000039528273,0.0005671461],"domain_scores_gemma":[0.99858034,0.00016288753,0.0005933545,0.00042210604,0.000021471573,0.00021984545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045491586,0.0002186852,0.00080705027,0.0004047546,0.000046130244,0.000017701079,0.00036165185,0.000053188352,0.0004009138],"category_scores_gemma":[0.000058122925,0.00021097102,0.00013213596,0.00019796645,0.0000262322,0.00026216,0.00009942665,0.00013027595,0.00013880237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002672618,0.000037632828,0.87776935,0.00008946218,0.00012104288,0.00000749637,0.00013757664,0.00029052523,0.000021820266,0.10022863,0.0033285697,0.017941153],"study_design_scores_gemma":[0.0048967754,0.000045067725,0.38353878,0.000070748705,0.000025955147,0.0000020365653,0.00028502534,0.0010534436,0.0008251046,0.014026572,0.59426373,0.0009667281],"about_ca_topic_score_codex":0.9860527,"about_ca_topic_score_gemma":0.973613,"teacher_disagreement_score":0.5909352,"about_ca_system_score_codex":0.0019605947,"about_ca_system_score_gemma":0.00041381034,"threshold_uncertainty_score":0.86031485},"labels":[],"label_agreement":null},{"id":"W4233084705","doi":"10.1007/s40274-016-2726-9","title":"Mental health associated with higher healthcare costs in Canada","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Health economics; Public health; Mental healthcare; Mental health; Health administration; Business; Environmental health; Medicine; Psychiatry; Nursing; Economics; Economic growth","score_opus":0.04309049664462562,"score_gpt":0.31216293918346,"score_spread":0.2690724425388344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233084705","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2864572,0.001063442,0.00005929531,0.7012778,0.0018851674,0.001023181,0.0016745565,0.000069136186,0.006490249],"genre_scores_gemma":[0.90456134,0.0010013285,0.000067764726,0.092249155,0.000070183494,0.00007505562,0.00004003438,0.000051803116,0.0018833524],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972307,0.00007117075,0.0011348671,0.0005974653,0.00005749434,0.0009083195],"domain_scores_gemma":[0.99846417,0.0001368964,0.00062338094,0.00035132936,0.000017746925,0.0004064611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005459141,0.00030133064,0.0008116136,0.00024066532,0.00011873128,0.00003439494,0.00033016264,0.000057018075,0.00055135373],"category_scores_gemma":[0.000029330633,0.0002615534,0.00008250083,0.00017221703,0.00002754287,0.0002783772,0.00009265868,0.00018973133,0.00022901544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050360984,0.000090691545,0.8604995,0.000042552532,0.00016143537,0.00001145666,0.00021412673,0.000017787523,0.0000016634654,0.077192806,0.04541943,0.016298182],"study_design_scores_gemma":[0.004640249,0.000090179325,0.32735732,0.00008001035,0.000003792151,0.0000017985662,0.00011015307,0.00012031772,0.00001687325,0.0016166592,0.66536635,0.0005962808],"about_ca_topic_score_codex":0.97068506,"about_ca_topic_score_gemma":0.98589265,"teacher_disagreement_score":0.61994696,"about_ca_system_score_codex":0.009324701,"about_ca_system_score_gemma":0.00088446983,"threshold_uncertainty_score":0.99998367},"labels":[],"label_agreement":null},{"id":"W4233304861","doi":"10.1007/bf03276005","title":"Opioid analgesics underused for neuropathic pain in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Medicine; Opioid; Pain management; Quality of Life Research; Anesthesia; Intensive care medicine; Public health; Nursing; Internal medicine","score_opus":0.024951935013929692,"score_gpt":0.30406136471552836,"score_spread":0.2791094297015987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233304861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764938,0.00034808888,0.0039583114,0.011649129,0.0013182819,0.0018219206,0.00003077613,0.00006806577,0.004311674],"genre_scores_gemma":[0.91777337,0.00035487665,0.0014526395,0.07886349,0.00009862867,0.00009659834,0.000035986275,0.00006254071,0.001261901],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983874,0.00019683929,0.00049440935,0.0003548243,0.00010027771,0.0004662405],"domain_scores_gemma":[0.9987321,0.0006145839,0.00012379317,0.00030301872,0.00002570189,0.00020081652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012296032,0.00024194657,0.000477609,0.00015275044,0.000055604018,0.000027099912,0.00016335084,0.000039949973,0.0001547881],"category_scores_gemma":[0.00037302068,0.00024312835,0.00013659355,0.00012438835,0.000014561803,0.00008518988,0.000027236334,0.00020605158,0.000019199619],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008788104,0.0000834407,0.9515765,0.000150778,0.00010596778,0.00005086147,0.00006694946,0.00034659167,0.0001883161,0.0018067387,0.03385725,0.011678729],"study_design_scores_gemma":[0.010116946,0.00011758361,0.15406081,0.000033803855,0.00021590054,0.0000028160684,0.00043618956,0.031624265,0.00095714943,0.0014887493,0.80027264,0.00067311345],"about_ca_topic_score_codex":0.14492251,"about_ca_topic_score_gemma":0.4664726,"teacher_disagreement_score":0.7975157,"about_ca_system_score_codex":0.00072730874,"about_ca_system_score_gemma":0.00096594857,"threshold_uncertainty_score":0.99144864},"labels":[],"label_agreement":null},{"id":"W4233363111","doi":"10.1007/s40274-020-6608-9","title":"Screening for congenital adrenal hyperplasia cost effective in Canada","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Congenital adrenal hyperplasia; Quality of Life Research; Medicine; Hyperplasia; Public health; Internal medicine; Pathology","score_opus":0.021459879655402664,"score_gpt":0.30667880108023204,"score_spread":0.2852189214248294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233363111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931562,0.00013847805,0.0024604828,0.0023116202,0.00030285568,0.0009633533,0.00020987204,0.000009051735,0.0004481123],"genre_scores_gemma":[0.9742256,0.000018226905,0.00022499078,0.024770575,0.00011179535,0.00017784702,0.00039474748,0.00002313212,0.00005307946],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991828,0.000028396104,0.00022434007,0.000295178,0.00004050771,0.00022874745],"domain_scores_gemma":[0.99962145,0.000053041702,0.000069985814,0.00008512706,0.000018969378,0.00015141752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038477534,0.00015705655,0.00020111311,0.00002357682,0.000036581227,0.000021147367,0.0001446902,0.000041074796,0.000072180585],"category_scores_gemma":[0.000056643825,0.00016751919,0.0000827792,0.000031716576,0.0000123609625,0.000006715874,0.0000539775,0.000073486786,0.000007492617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008840394,0.00006520504,0.8769719,0.000040359166,0.00041079542,0.0000046605687,0.0001760021,0.0027684486,0.037678335,0.00008694673,0.03279489,0.048118442],"study_design_scores_gemma":[0.025650434,0.00038950104,0.24901854,0.000008052324,0.00016772012,0.000010118627,0.0022037819,0.032865804,0.12406046,0.000046368914,0.56393147,0.0016477415],"about_ca_topic_score_codex":0.06728778,"about_ca_topic_score_gemma":0.46793652,"teacher_disagreement_score":0.62795335,"about_ca_system_score_codex":0.00006684469,"about_ca_system_score_gemma":0.00023644844,"threshold_uncertainty_score":0.93892324},"labels":[],"label_agreement":null},{"id":"W4233484819","doi":"10.2165/00151234-201106250-00011","title":"Dabigatran etexilate highly cost effective in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Quality of Life Research; Computer science; Medicine; Public health; Internal medicine","score_opus":0.060221816165151834,"score_gpt":0.3435310277547639,"score_spread":0.2833092115896121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233484819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96858335,0.0000865409,0.000031395673,0.007237815,0.0014109395,0.002177582,0.000021639842,0.00006545895,0.020385278],"genre_scores_gemma":[0.9870618,0.00012740532,0.00034346472,0.010916874,0.00022667643,0.000039244664,0.000025202859,0.000041512267,0.0012178094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985101,0.000054222226,0.00056436966,0.00035183298,0.00011681223,0.00040264396],"domain_scores_gemma":[0.9991295,0.00017698224,0.00016363883,0.00027492543,0.000026001553,0.00022898574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018729923,0.0002695853,0.00062657695,0.00018209156,0.000047080564,0.000016492993,0.0001577957,0.00004967238,0.00080188725],"category_scores_gemma":[0.000031949356,0.00024715628,0.00018565421,0.00013411393,0.000024258916,0.0001989115,0.00007146046,0.0002126109,0.00018244922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027397802,0.000011279249,0.976256,0.000034983783,0.00018058233,0.00006774663,0.0002117892,0.000069112866,0.0003167836,0.00045932404,0.0026190395,0.019499369],"study_design_scores_gemma":[0.005004079,0.000039058537,0.8791682,0.0000141919245,0.00016386829,0.0000071306713,0.00014873271,0.0006700731,0.004250584,0.00014390502,0.11006831,0.00032184238],"about_ca_topic_score_codex":0.6199163,"about_ca_topic_score_gemma":0.6552809,"teacher_disagreement_score":0.10744926,"about_ca_system_score_codex":0.00088876014,"about_ca_system_score_gemma":0.00036993218,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W4233544818","doi":"10.1007/bf03276687","title":"Healthcare administration costs huge in the US vs Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Quality and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health administration; Quality of Life Research; Health care; Administration (probate law); Health economics; Business; Public health; Public administration; Public economics; Medicine; Economics; Political science; Economic growth; Nursing; Law","score_opus":0.08790370956313619,"score_gpt":0.4825034681273154,"score_spread":0.3945997585641792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233544818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6688233,0.0001629371,0.000028318285,0.30530858,0.0028111332,0.0021930586,0.00009608572,0.000046148725,0.020530421],"genre_scores_gemma":[0.70892245,0.00022504306,0.00007094707,0.28951162,0.00011467609,0.0002554997,0.00003879025,0.000019058529,0.00084193324],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957178,0.0019018039,0.0010687567,0.00035468687,0.00019303073,0.0007639207],"domain_scores_gemma":[0.9980849,0.00085225597,0.0003110429,0.0004574238,0.00005297018,0.00024140262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019751373,0.00022667623,0.0004014143,0.00008147142,0.0005426969,0.00002357441,0.00035491437,0.00011213014,0.00045149252],"category_scores_gemma":[0.00015612479,0.0001871884,0.00007007473,0.00014487651,0.000019643363,0.00015224966,0.000046356647,0.0008108076,0.00018056048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121673715,0.00014332334,0.62957865,0.00056621444,0.00005959837,0.000054814995,0.0033057178,0.00004365695,0.0000060034754,0.124338016,0.2337878,0.007994516],"study_design_scores_gemma":[0.0012222842,0.000038602815,0.063615225,0.000023932347,0.000013794035,0.0000020122484,0.005277525,0.00004725462,0.000016617872,0.00042620543,0.92911017,0.00020638823],"about_ca_topic_score_codex":0.7569471,"about_ca_topic_score_gemma":0.9809833,"teacher_disagreement_score":0.69532233,"about_ca_system_score_codex":0.0016991033,"about_ca_system_score_gemma":0.0030334122,"threshold_uncertainty_score":0.7633321},"labels":[],"label_agreement":null},{"id":"W4234163504","doi":"10.1007/bf03267040","title":"Canada's health system restricts drug access","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Drug; Health economics; Business; Environmental health; Medicine; Pharmacology; Nursing","score_opus":0.05204346335349221,"score_gpt":0.34481938233646964,"score_spread":0.29277591898297745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234163504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4669187,0.005010622,0.000075225274,0.22799346,0.0045784097,0.0015540117,0.00409961,0.00038532796,0.28938463],"genre_scores_gemma":[0.84214646,0.0025850064,0.00015440218,0.14820977,0.000527664,0.00008519354,0.00006616832,0.0001122645,0.0061130947],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958774,0.000057521323,0.001960968,0.000918762,0.00005492444,0.001130411],"domain_scores_gemma":[0.99750656,0.00017730081,0.0007220483,0.0007108476,0.000020124351,0.0008631233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00066582696,0.0005016398,0.0013350942,0.00026414395,0.00031675037,0.00035020793,0.0012520537,0.00008824339,0.0043838294],"category_scores_gemma":[0.000025469832,0.00060388027,0.0003054431,0.0002364215,0.000051944076,0.0006392839,0.00017309966,0.00043717874,0.0027237812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008212475,0.00015879015,0.06761753,0.00020510363,0.00045215592,0.000024853365,0.00024748305,0.0027196493,0.0000023402147,0.12089738,0.7862963,0.021296259],"study_design_scores_gemma":[0.0016828082,0.000013613574,0.009542703,0.0000120099585,0.000014989807,0.000012306358,0.00003428415,0.006622483,0.000043736512,0.0018434504,0.9795212,0.00065639475],"about_ca_topic_score_codex":0.7155321,"about_ca_topic_score_gemma":0.22920483,"teacher_disagreement_score":0.4863273,"about_ca_system_score_codex":0.0017849773,"about_ca_system_score_gemma":0.0008503885,"threshold_uncertainty_score":0.99964124},"labels":[],"label_agreement":null},{"id":"W4234530602","doi":"10.1007/s40274-013-0236-6","title":"Pharmacists could save Ontario's public health system big $","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Health economics; Business; Environmental health; Medicine; Nursing","score_opus":0.160703422337893,"score_gpt":0.34024375975838494,"score_spread":0.17954033742049194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234530602","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3210753,0.00269552,0.004813602,0.45457265,0.013959411,0.005417476,0.000844361,0.0009966549,0.19562502],"genre_scores_gemma":[0.9084018,0.0005902944,0.00066796766,0.08075554,0.00046925485,0.000456931,0.00006400957,0.00009684122,0.008497384],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955101,0.00008181457,0.0020240839,0.0009301907,0.00007200708,0.0013817968],"domain_scores_gemma":[0.9970786,0.000110502246,0.0010451301,0.0007562051,0.000055647455,0.00095393974],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001220404,0.0005072348,0.0012365985,0.0005734433,0.00032333756,0.00042503927,0.0007510739,0.00013293546,0.0030123182],"category_scores_gemma":[0.00003670089,0.0005858679,0.00037643447,0.00020581347,0.00005698025,0.0007361164,0.00026162542,0.0005070479,0.011396096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021061416,0.0004302309,0.21817377,0.00063645333,0.0008653603,0.000016364245,0.0033525059,0.00010407019,0.000011024281,0.48366997,0.21401483,0.078704365],"study_design_scores_gemma":[0.0019041083,0.00004990615,0.014524765,0.000010591627,0.000010155768,0.000013171943,0.00020102938,0.0017792024,0.000016483556,0.00247749,0.97839534,0.0006177715],"about_ca_topic_score_codex":0.2632222,"about_ca_topic_score_gemma":0.020000579,"teacher_disagreement_score":0.7643805,"about_ca_system_score_codex":0.0031566399,"about_ca_system_score_gemma":0.00035952296,"threshold_uncertainty_score":0.9996593},"labels":[],"label_agreement":null},{"id":"W4234596508","doi":"10.2165/00151234-200504830-00043","title":"Trastuzumab to be provided free in British Columbia","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.04803241967852492,"score_gpt":0.3218295073160283,"score_spread":0.2737970876375034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234596508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8955699,0.00063333276,0.00010655839,0.07243314,0.00096509774,0.0010581549,0.0013544101,0.000119271346,0.027760139],"genre_scores_gemma":[0.8397127,0.0004543648,0.0015917799,0.15306328,0.0004950543,0.0002276368,0.00003175647,0.00011216015,0.004311257],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597645,0.000030053303,0.0018276768,0.0009996908,0.000041056763,0.0011250693],"domain_scores_gemma":[0.998058,0.00015095896,0.0003827513,0.0007096353,0.000021313565,0.0006773129],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00074510346,0.00032781268,0.0011420328,0.00032094854,0.0001383813,0.000773762,0.0011099117,0.00015972326,0.004778081],"category_scores_gemma":[0.00018523357,0.0006319182,0.00034334304,0.00025437598,0.000039866063,0.00073225657,0.00035840785,0.0004515028,0.0027490174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000648445,0.00086426723,0.5451635,0.0000662215,0.00033906425,0.000031398693,0.0013432606,0.0030901646,0.000091553884,0.01824784,0.3912028,0.039495032],"study_design_scores_gemma":[0.0039913524,0.00004618854,0.042504977,0.000008603437,0.000015531445,0.000013726304,0.00006512801,0.005641128,0.000054987773,0.009622189,0.9371986,0.0008376246],"about_ca_topic_score_codex":0.03459939,"about_ca_topic_score_gemma":0.2510622,"teacher_disagreement_score":0.5459958,"about_ca_system_score_codex":0.0009177133,"about_ca_system_score_gemma":0.00010720617,"threshold_uncertainty_score":0.9996132},"labels":[],"label_agreement":null},{"id":"W4234833161","doi":"10.2165/00151234-201206550-00032","title":"Benefits of Crestor card continue in Canada","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine","score_opus":0.05884608121265341,"score_gpt":0.3099594378561737,"score_spread":0.2511133566435203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234833161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659951,0.0030443508,0.000037297934,0.011448349,0.0020184538,0.00038125375,0.0004255856,0.000015454192,0.016634159],"genre_scores_gemma":[0.9872535,0.00059914705,0.00020309583,0.011200523,0.00017287087,0.000042609146,0.000011534124,0.000029942335,0.00048680996],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979702,0.000023938495,0.0010804354,0.00026923502,0.00003161849,0.00062455935],"domain_scores_gemma":[0.9988763,0.00011135611,0.00044036043,0.00031901678,0.000013454973,0.00023952447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050168694,0.00019800298,0.00070487347,0.00023307394,0.00003400218,0.000014644884,0.00029744385,0.000050966686,0.00031153645],"category_scores_gemma":[0.000054599263,0.00024351597,0.00011545512,0.000111670546,0.000017373797,0.00028739404,0.00010370464,0.00016327205,0.00018671581],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000115528455,0.000053577616,0.88638395,0.00005372892,0.000063060164,7.1776094e-7,0.00033051625,0.0004675611,0.0000020152456,0.0989913,0.008175067,0.0054669357],"study_design_scores_gemma":[0.0010581086,0.000010614467,0.48519623,0.000007834765,0.000008785708,0.0000010342526,0.00013332989,0.00025823648,0.00016457474,0.0006241341,0.51222384,0.000313246],"about_ca_topic_score_codex":0.9666397,"about_ca_topic_score_gemma":0.89243627,"teacher_disagreement_score":0.50404876,"about_ca_system_score_codex":0.00091374427,"about_ca_system_score_gemma":0.00019175911,"threshold_uncertainty_score":0.9930293},"labels":[],"label_agreement":null},{"id":"W4235063194","doi":"10.1007/s40274-018-5025-9","title":"Midostaurin a cost-effective option for AML in Canada","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Midostaurin; Medicine; Public health; Leukemia; Internal medicine; Nursing","score_opus":0.015649525705426055,"score_gpt":0.35152467229114187,"score_spread":0.3358751465857158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235063194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946501,0.00010512471,0.00047317997,0.0014203067,0.0006630648,0.0019038268,0.00014423052,0.000007617872,0.00063249725],"genre_scores_gemma":[0.9936356,0.00006760216,0.00037650406,0.0037091947,0.0004598027,0.0008396576,0.00012250854,0.000040947867,0.00074817543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872345,0.00006405804,0.0002980304,0.00042038097,0.00007112199,0.00042298462],"domain_scores_gemma":[0.99936736,0.00006664364,0.000085495296,0.00026158418,0.00007769636,0.00014123031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020823638,0.0001829774,0.00023197275,0.00007958582,0.00007765482,0.000021197357,0.00022859397,0.000069299334,0.000053141623],"category_scores_gemma":[0.00008132515,0.00019748173,0.00009566398,0.00005605513,0.000056939236,0.000008576113,0.00009889287,0.0001137052,0.000040526324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015373587,0.00020934797,0.06803233,0.00009079507,0.00030113055,0.000016088537,0.00024502416,0.0007296511,0.64534163,0.00016135439,0.18212925,0.10120604],"study_design_scores_gemma":[0.0024942807,0.00013348115,0.0037840807,0.0000049304313,0.000010766104,0.0000044316953,0.00007651265,0.0015774248,0.4971408,0.000024616258,0.49447522,0.00027345287],"about_ca_topic_score_codex":0.29752126,"about_ca_topic_score_gemma":0.8759844,"teacher_disagreement_score":0.57846314,"about_ca_system_score_codex":0.0007451126,"about_ca_system_score_gemma":0.0007574577,"threshold_uncertainty_score":0.80530715},"labels":[],"label_agreement":null},{"id":"W4235510047","doi":"10.2165/00151234-200705250-00014","title":"Pregnancy during isotretinoin use “frequent” in Canada","year":2007,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Isotretinoin; Pregnancy; Medicine; Public health; Obstetrics; Dermatology; Nursing","score_opus":0.012392086816790686,"score_gpt":0.28151399104628083,"score_spread":0.26912190422949017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235510047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895985,0.0016750621,0.000049247574,0.00027504814,0.006780791,0.0002665604,0.00004941992,0.000011698266,0.0012936378],"genre_scores_gemma":[0.9901678,0.0021652875,0.00030722911,0.0031349638,0.0022223883,0.000025223286,0.00004580685,0.000050648403,0.0018806424],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998451,0.000036216843,0.00048176298,0.00042229102,0.000074359064,0.000534393],"domain_scores_gemma":[0.99927664,0.000034379176,0.00013647144,0.0003394429,0.000024085575,0.00018897792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014426497,0.00024156734,0.00029683136,0.000076833014,0.000049058148,0.00002893404,0.00022625117,0.000072378665,0.00008840546],"category_scores_gemma":[0.000051069226,0.0002610141,0.000118414435,0.000055755296,0.00002134192,0.00001619379,0.00008474591,0.00014944538,0.000011106302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012431992,0.000053857668,0.85554755,0.00003921488,0.00010199593,0.0000043146388,0.00008260076,0.00038427612,0.12316243,0.00016603983,0.014218007,0.0061153667],"study_design_scores_gemma":[0.0025267508,0.000011994986,0.19262818,0.00001677856,0.000024897314,0.000013382854,0.00011015843,0.000017261691,0.08414002,0.000018656798,0.72004205,0.0004498956],"about_ca_topic_score_codex":0.52555513,"about_ca_topic_score_gemma":0.9340745,"teacher_disagreement_score":0.705824,"about_ca_system_score_codex":0.00031424058,"about_ca_system_score_gemma":0.00062213704,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W4235534330","doi":"10.2165/00151234-200404500-00049","title":"Medical association welcomes Canadian govt funding initiative","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Association (psychology); Public health; Health economics; Business; Medicine; Psychology","score_opus":0.07055426202808049,"score_gpt":0.4584102226975196,"score_spread":0.38785596066943906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235534330","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20816067,0.00031046642,0.00011671023,0.53330046,0.009642037,0.0014066317,0.00031360862,0.00035160402,0.24639782],"genre_scores_gemma":[0.35116816,0.001429189,0.0003949361,0.64153945,0.00132594,0.00021062208,0.00010429564,0.00008693016,0.0037404818],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957085,0.000377068,0.001320936,0.00049388764,0.00043853035,0.0016610292],"domain_scores_gemma":[0.9959626,0.0015218911,0.0006043799,0.00035347493,0.00016625132,0.0013913785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018093014,0.00037853114,0.0008360932,0.00040151377,0.0012061186,0.000039974802,0.0005731906,0.0005627068,0.009643057],"category_scores_gemma":[0.00066248496,0.00036915333,0.000257508,0.00020782645,0.00003598268,0.0005523554,0.00019218108,0.0016796893,0.006829515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000026470967,0.000041726176,0.74381435,0.000087336775,0.00022518686,0.000039491635,0.0019762185,0.000023947237,0.000009134476,0.010122016,0.24029088,0.0033432774],"study_design_scores_gemma":[0.0046390505,0.000031179734,0.12537028,0.000041758933,0.00007367787,0.0000037702735,0.0011378608,0.000034118322,0.000033642373,0.0032267594,0.86491126,0.0004966348],"about_ca_topic_score_codex":0.16035183,"about_ca_topic_score_gemma":0.47314554,"teacher_disagreement_score":0.6246204,"about_ca_system_score_codex":0.014210366,"about_ca_system_score_gemma":0.01112246,"threshold_uncertainty_score":0.999876},"labels":[],"label_agreement":null},{"id":"W4235709219","doi":"10.2165/00151234-201106430-00009","title":"First-line tenofovir best for chronic hepatitis B in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tenofovir; Chronic hepatitis; Quality of Life Research; Medicine; Virology; Public health; Human immunodeficiency virus (HIV); Virus; Nursing","score_opus":0.051749024554450594,"score_gpt":0.3229490111454052,"score_spread":0.2711999865909546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235709219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823575,0.0009838168,0.00013088937,0.008604487,0.0013394136,0.0016117379,0.00028666123,0.000051789164,0.0046337284],"genre_scores_gemma":[0.97928166,0.0040693507,0.0013052283,0.013527197,0.00028626245,0.00036932054,0.000033819964,0.00007278305,0.0010544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981606,0.00001963229,0.00070349383,0.00041001858,0.0000996017,0.00060662633],"domain_scores_gemma":[0.9990197,0.00019930342,0.00016394461,0.00032547934,0.000060106417,0.00023146458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013661738,0.0003098165,0.0007760577,0.00013636694,0.00009711182,0.000011010626,0.00019942364,0.000054859935,0.00079867715],"category_scores_gemma":[0.000085578664,0.0003014413,0.00015674175,0.00008413623,0.0000398962,0.00014239579,0.00009875939,0.00020730784,0.00014868058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008740748,0.000105364175,0.9762873,0.00013895164,0.00019237954,0.000052538642,0.00027137357,0.000053091175,0.00004741568,0.00009758196,0.0120877875,0.010578827],"study_design_scores_gemma":[0.0077018407,0.00035683246,0.675327,0.000085272375,0.00027565658,0.000020999345,0.00006911563,0.005297189,0.00239724,0.00026183107,0.3075549,0.0006520811],"about_ca_topic_score_codex":0.98488504,"about_ca_topic_score_gemma":0.99896526,"teacher_disagreement_score":0.30096024,"about_ca_system_score_codex":0.0027421154,"about_ca_system_score_gemma":0.0014437971,"threshold_uncertainty_score":0.9999438},"labels":[],"label_agreement":null},{"id":"W4236444549","doi":"10.1007/bf03275733","title":"Resource use low among Canadian women with psychiatric disorders","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Psychiatry; Resource (disambiguation); Public health; Resource use; Psychology; Medicine; Computer science; Economics; Nursing","score_opus":0.014263721691507206,"score_gpt":0.3104943048282689,"score_spread":0.2962305831367617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236444549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9179072,0.0000828097,0.00001484938,0.021764958,0.001006606,0.0006122704,0.000036538782,0.000092251874,0.05848252],"genre_scores_gemma":[0.9297081,0.0005879546,0.00036156853,0.06106484,0.0001728482,0.00009758168,0.0000065763306,0.00006000796,0.007940499],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721885,0.0002651172,0.0004281361,0.0004165374,0.00017925056,0.0014920869],"domain_scores_gemma":[0.99764466,0.00034647287,0.00016742578,0.00031550895,0.000030591033,0.0014953117],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070003566,0.00027480326,0.00040566458,0.0002545129,0.0009578509,0.00030803826,0.00039961428,0.000119292985,0.0013447942],"category_scores_gemma":[0.00014557634,0.0002589306,0.000107981956,0.00028503488,0.00018423721,0.00063596125,0.000020578898,0.00025220015,0.00011756437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019476405,0.000032516196,0.96506953,0.000022150844,0.000050415394,0.0000035158575,0.0035218734,0.00014383346,9.3721575e-8,0.0104461005,0.019043857,0.0016466451],"study_design_scores_gemma":[0.0008074346,0.000016467447,0.16946185,0.000004911437,0.000018231489,5.2933405e-7,0.0049634464,0.000018444256,0.0000013537415,0.00039957586,0.82396585,0.00034189477],"about_ca_topic_score_codex":0.55842215,"about_ca_topic_score_gemma":0.91596663,"teacher_disagreement_score":0.804922,"about_ca_system_score_codex":0.0011100086,"about_ca_system_score_gemma":0.001367516,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W4236445904","doi":"10.1007/s40274-020-7285-4","title":"Non-invasive prenatal Down syndrome screening \"affordable\" in Canada","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Pathology","score_opus":0.021415011980702923,"score_gpt":0.282073091242399,"score_spread":0.26065807926169604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236445904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726002,0.00021767465,0.00025064204,0.022664942,0.00037618622,0.0006113637,0.00017925266,0.000077421144,0.0030222754],"genre_scores_gemma":[0.9529469,0.00012604089,0.0016918334,0.044745523,0.00014097906,0.0000356958,0.00012605818,0.000049782262,0.00013717044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980824,0.000025388128,0.00061648735,0.00049470604,0.00019060857,0.00059042213],"domain_scores_gemma":[0.9984122,0.0004094468,0.00016467,0.00027192067,0.000032033382,0.0007097218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000104473824,0.00033528285,0.0007473828,0.000099404795,0.00006276742,0.000040288836,0.00030889662,0.000069888214,0.00035590254],"category_scores_gemma":[0.00025833707,0.00032749734,0.00015241349,0.00017615934,0.000028540604,0.00024364982,0.00021279597,0.0004935984,0.00011797474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027238604,0.000052321837,0.96668804,0.00018046796,0.00022049967,0.0014544346,0.00023884911,0.0034416039,0.00018905956,0.000035552603,0.020908989,0.0063178055],"study_design_scores_gemma":[0.026563862,0.0006451951,0.8391694,0.00057114667,0.0006051856,0.00068620883,0.0018401645,0.06577175,0.018410346,0.00008069529,0.043450054,0.0022060254],"about_ca_topic_score_codex":0.6928813,"about_ca_topic_score_gemma":0.51920444,"teacher_disagreement_score":0.17367688,"about_ca_system_score_codex":0.00051026815,"about_ca_system_score_gemma":0.0013870078,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W4236788575","doi":"10.2165/00151234-200605110-00006","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Ezetimibe; Quality of Life Research; Business; Public health; Medicine; Pharmacology; Statin; Internal medicine","score_opus":0.043245420535249504,"score_gpt":0.35861665981557744,"score_spread":0.31537123928032795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236788575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796742,0.00035176115,0.0005045249,0.016083281,0.0006567697,0.0018970496,0.00005486411,0.000029166176,0.00074838963],"genre_scores_gemma":[0.9547383,0.00014288802,0.0024800114,0.041213304,0.0005313449,0.00032256602,0.000034389406,0.000045671233,0.000491508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849653,0.00003781881,0.0004997107,0.0003801542,0.00017876927,0.00040698668],"domain_scores_gemma":[0.99908626,0.00018797192,0.00009625708,0.0003572484,0.000047148467,0.00022513517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037731446,0.00019898753,0.00051052734,0.00011532565,0.000049205548,0.000019767922,0.0001136052,0.00003750362,0.00010943309],"category_scores_gemma":[0.00006518225,0.0001881305,0.0002052655,0.000097168246,0.00000703048,0.00009969642,0.00002782335,0.00014805779,0.00004897036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017398852,0.00023692084,0.59811145,0.00059701834,0.0002614709,0.00008077617,0.00015878302,0.013759016,0.0011452832,0.00093850907,0.20184839,0.18112251],"study_design_scores_gemma":[0.009240512,0.00031606742,0.5623506,0.00024408063,0.00019805123,0.00002555738,0.00020298305,0.003064502,0.005029025,0.00015033915,0.41849735,0.00068096246],"about_ca_topic_score_codex":0.80401564,"about_ca_topic_score_gemma":0.7959099,"teacher_disagreement_score":0.21664897,"about_ca_system_score_codex":0.0016860733,"about_ca_system_score_gemma":0.0011559483,"threshold_uncertainty_score":0.76717395},"labels":[],"label_agreement":null},{"id":"W4237000794","doi":"10.2165/00151234-201106310-00025","title":"Febuxostat, dexlansoprazole reimbursed in Quebec","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Febuxostat; Quality of Life Research; Business; Medicine; Public health; Internal medicine; Nursing","score_opus":0.04945966627069039,"score_gpt":0.36785061744353953,"score_spread":0.31839095117284916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237000794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94835985,0.00035883585,0.0000114468585,0.0054063727,0.0009973845,0.00066753285,0.000023679437,0.00010921696,0.04406566],"genre_scores_gemma":[0.9590702,0.00057321286,0.0007450871,0.024812443,0.00020455431,0.0001244067,0.00005973408,0.000060493283,0.01434988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985278,0.000045532674,0.0005033347,0.00039217182,0.00006996375,0.00046115374],"domain_scores_gemma":[0.9992285,0.00008193054,0.00013006326,0.00028033834,0.000026128237,0.0002530442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012873164,0.0002820794,0.000582083,0.0002557306,0.000040795374,0.000016178012,0.00016133738,0.00009120302,0.004424545],"category_scores_gemma":[0.000009715102,0.00026355337,0.00019846944,0.000121856996,0.000055298944,0.00020324049,0.00005438461,0.00028483348,0.0005880751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010746163,0.0007920787,0.94478554,0.000038644805,0.00036079326,0.00024466604,0.0017322002,0.0000100301695,0.002577114,0.00038343802,0.028945243,0.019055625],"study_design_scores_gemma":[0.022531407,0.00033102368,0.65100336,0.00002700561,0.00060923427,0.00006428265,0.0003871645,0.00041865022,0.020596016,0.0004361038,0.30291298,0.00068275974],"about_ca_topic_score_codex":0.045799058,"about_ca_topic_score_gemma":0.03183298,"teacher_disagreement_score":0.29378217,"about_ca_system_score_codex":0.00044631684,"about_ca_system_score_gemma":0.00022601034,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W4237553453","doi":"10.2165/00151234-201006130-00020","title":"Insulin initiation: cost-effective options in Canada?","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Insulin; Economics; Public health; Medicine; Internal medicine; Nursing","score_opus":0.02967356865642003,"score_gpt":0.3619676933345514,"score_spread":0.3322941246781314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237553453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485924,0.000082981496,0.00002237519,0.017855117,0.0014388956,0.0022792318,0.0000680628,0.00005956413,0.029601319],"genre_scores_gemma":[0.98354995,0.00016306447,0.00020033568,0.014967962,0.00020033146,0.00048802304,0.00009048443,0.00002792083,0.0003119215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998864,0.000029463687,0.00038680318,0.0003035036,0.000103521816,0.00031269525],"domain_scores_gemma":[0.9991722,0.0001663033,0.00011025752,0.00030594223,0.00003396475,0.0002113442],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001388913,0.00019809153,0.00035160474,0.00016351232,0.00004883079,0.000038793307,0.00014964599,0.000039892322,0.0018839351],"category_scores_gemma":[0.000057785925,0.00020449221,0.000089140965,0.000118974116,0.000032919204,0.00022760245,0.000075814314,0.00040320356,0.00015131882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029727825,0.00049462426,0.85384566,0.00020163477,0.0004897183,0.0002448813,0.000278305,0.0017010297,0.0012702774,0.013618812,0.05236557,0.07519219],"study_design_scores_gemma":[0.0063127563,0.000022515413,0.77764904,0.000013806018,0.0001457382,0.000011175392,0.00034476977,0.0033619513,0.0003319302,0.00038177965,0.21112485,0.0002996817],"about_ca_topic_score_codex":0.37653413,"about_ca_topic_score_gemma":0.8829099,"teacher_disagreement_score":0.5063758,"about_ca_system_score_codex":0.0010627644,"about_ca_system_score_gemma":0.0015015774,"threshold_uncertainty_score":0.9990285},"labels":[],"label_agreement":null},{"id":"W4237991971","doi":"10.1007/bf03276098","title":"Outpatient treatment with LMWHs cost saving for DVT in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Business; Nursing","score_opus":0.034300354717029795,"score_gpt":0.33486820175065674,"score_spread":0.30056784703362693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237991971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97515076,0.00039896683,0.0000888547,0.0012710587,0.0005407419,0.0011232786,0.00007075995,0.00002414614,0.021331428],"genre_scores_gemma":[0.9940715,0.00020030736,0.0005701618,0.0040559135,0.000054139255,0.00015641995,0.000017866105,0.000027862321,0.0008458325],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990239,0.00002281557,0.0003287003,0.00025817862,0.000074534735,0.00029186127],"domain_scores_gemma":[0.99930936,0.00024080511,0.00010136103,0.00017322287,0.000037967824,0.0001373006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008118985,0.00020007587,0.0006175322,0.000078818775,0.000063314656,0.000014520301,0.0000143378165,0.000021698392,0.000023925779],"category_scores_gemma":[0.000029306448,0.0001560343,0.00012150177,0.000056732104,0.000012834676,0.0000464536,0.000009640593,0.000059079503,0.000010200786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024343973,0.000047276993,0.98495203,0.000024426665,0.00029653436,0.000008232597,0.00031568095,0.0011425252,0.000043626587,0.00010711724,0.0059185657,0.006900552],"study_design_scores_gemma":[0.009835024,0.00020473852,0.06428748,0.0000240617,0.00022335458,0.00005394753,0.00088920246,0.00024332869,0.0012616117,0.000011530402,0.92265844,0.0003072929],"about_ca_topic_score_codex":0.31348503,"about_ca_topic_score_gemma":0.61643785,"teacher_disagreement_score":0.92066455,"about_ca_system_score_codex":0.0018625874,"about_ca_system_score_gemma":0.0007649763,"threshold_uncertainty_score":0.69108653},"labels":[],"label_agreement":null},{"id":"W4238317182","doi":"10.1007/bf03269190","title":"Which TB screening method for immigrants to Canada?","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immigration; Quality of Life Research; Public health; Political science; Medicine; Law; Nursing","score_opus":0.05501685564534359,"score_gpt":0.4369387218149321,"score_spread":0.3819218661695885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238317182","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31637177,0.00021138668,0.02700859,0.6496154,0.00077366695,0.0017485234,0.00015597195,0.00008657616,0.0040280833],"genre_scores_gemma":[0.2669908,0.00049531244,0.088268235,0.6374157,0.00089704414,0.0003782763,0.00013439008,0.000112650785,0.005307565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978079,0.000103963146,0.0005741679,0.00049895287,0.00012471371,0.0008902982],"domain_scores_gemma":[0.9976817,0.0009073278,0.000095943426,0.00035603956,0.0001266135,0.000832402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008287648,0.00025545675,0.00080238597,0.00017566286,0.00012293142,0.000022835318,0.00025449228,0.0000784014,0.00033987267],"category_scores_gemma":[0.0007613308,0.00022666661,0.00020253636,0.00016414335,0.000009670106,0.00007352663,0.000092479706,0.0002697278,0.000077967095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009867824,0.00006505855,0.30296215,0.00004793811,0.00055167,0.000024576771,0.00009227177,0.00085527444,0.0029956114,0.00014834084,0.60271084,0.08855945],"study_design_scores_gemma":[0.0031166435,0.00011438213,0.076076925,0.000012207327,0.00011148816,0.00006478754,0.0001307503,0.015086823,0.0011904652,0.00006482288,0.90375704,0.000273688],"about_ca_topic_score_codex":0.69951475,"about_ca_topic_score_gemma":0.8534567,"teacher_disagreement_score":0.30104613,"about_ca_system_score_codex":0.00033500005,"about_ca_system_score_gemma":0.0004715555,"threshold_uncertainty_score":0.9243196},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4238438364","doi":"10.1007/bf03276740","title":"Pharmaceutical sales rise by 14% in Canada, China","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; China; Business; Public health; Political science; Medicine; Law","score_opus":0.03730183461446839,"score_gpt":0.3188371479028117,"score_spread":0.2815353132883433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238438364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8608174,0.007772555,0.00016764435,0.02766632,0.0032087325,0.0008420942,0.0018596028,0.000084274274,0.09758142],"genre_scores_gemma":[0.9583903,0.002766737,0.00023670682,0.03700163,0.00011496951,0.00008526203,0.00004766042,0.00010552465,0.0012512299],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958569,0.000085653126,0.0018253728,0.00094977283,0.000055250857,0.0012270568],"domain_scores_gemma":[0.9980443,0.00023574007,0.00047552842,0.00051851996,0.000015483225,0.0007104045],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00078478415,0.00056553504,0.0012398898,0.00030565835,0.00012786334,0.00013166547,0.0006798221,0.00013772667,0.0038542615],"category_scores_gemma":[0.00014162775,0.00069746183,0.0002842976,0.00022870411,0.00008395893,0.00045768084,0.000119549026,0.00070813147,0.0017507551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006577478,0.00035036184,0.6543245,0.000057183745,0.00031005434,0.000030055307,0.00022283725,0.0008641853,0.00013325897,0.12721859,0.21410184,0.002321389],"study_design_scores_gemma":[0.0037289283,0.000015711184,0.013736768,0.000005166952,0.000023956098,0.000011250544,0.000050406197,0.00618301,0.000808617,0.011091871,0.96340334,0.00094095315],"about_ca_topic_score_codex":0.3888573,"about_ca_topic_score_gemma":0.28669405,"teacher_disagreement_score":0.7493015,"about_ca_system_score_codex":0.0016942587,"about_ca_system_score_gemma":0.00055792084,"threshold_uncertainty_score":0.99954766},"labels":[],"label_agreement":null},{"id":"W4238548979","doi":"10.1007/s40274-021-7747-3","title":"Ribociclib + NSAI may be cost effective for advanced breast cancer in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Breast cancer; Cancer; Medicine; Public health; Internal medicine","score_opus":0.015470597123697947,"score_gpt":0.3594825584680343,"score_spread":0.3440119613443363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238548979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89416945,0.002227797,0.00039345247,0.09276013,0.0026217217,0.004190009,0.0028549172,0.000086821725,0.0006956881],"genre_scores_gemma":[0.9278226,0.00071094936,0.0013202523,0.065233484,0.0003806139,0.0026840097,0.00012694873,0.00014107292,0.0015800727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798894,0.00005318517,0.00053939346,0.00062450935,0.00013408426,0.00065986835],"domain_scores_gemma":[0.9985474,0.00043037097,0.0002054696,0.00036767684,0.00015204276,0.00029703902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011397402,0.00037992102,0.0008972899,0.00009210876,0.0000743772,0.000022561415,0.00017060796,0.00006075716,0.0008738179],"category_scores_gemma":[0.00003893663,0.00038477057,0.00020378869,0.00016954962,0.000043342196,0.0002585568,0.000074474665,0.00031456954,0.000010441732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020126211,0.00015921802,0.46867624,0.00023617891,0.0006600135,0.00011946327,0.0002642372,0.0046405783,0.009581992,0.00016267311,0.0027686744,0.5107181],"study_design_scores_gemma":[0.031286996,0.000058083268,0.34919825,0.00016823706,0.00033097563,0.00022125647,0.0011848679,0.0018958282,0.053801876,0.00024810914,0.56058264,0.0010229108],"about_ca_topic_score_codex":0.30708125,"about_ca_topic_score_gemma":0.83416396,"teacher_disagreement_score":0.55781394,"about_ca_system_score_codex":0.004250716,"about_ca_system_score_gemma":0.002654016,"threshold_uncertainty_score":0.9998604},"labels":[],"label_agreement":null},{"id":"W4238611738","doi":"10.1007/bf03269365","title":"Formulary listing times drop in 4 Canadian provinces","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Listing (finance); Quality of Life Research; Business; Medicine; Public health; Finance; Family medicine","score_opus":0.048418104041826705,"score_gpt":0.3334772051408186,"score_spread":0.28505910109899185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238611738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6274456,0.0018124037,0.000057052854,0.032978214,0.00135107,0.00069500477,0.0003952786,0.000098890996,0.3351665],"genre_scores_gemma":[0.95956486,0.0014016095,0.000310566,0.03575219,0.00032121007,0.00006941111,0.00004231597,0.000077395795,0.0024604131],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965508,0.000024767365,0.0013924391,0.0007186265,0.000026756343,0.0012866282],"domain_scores_gemma":[0.99826306,0.00014848185,0.00039591698,0.00041407955,0.000016743194,0.0007617216],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007947841,0.00039654813,0.00087521353,0.0008002485,0.00017455188,0.00022129895,0.00066288235,0.00015487758,0.0029624612],"category_scores_gemma":[0.00011003173,0.0004871629,0.00026556107,0.00024526007,0.000064468695,0.00075183436,0.0001307171,0.00042579637,0.0032315797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029391505,0.00009329272,0.87650156,0.000025583166,0.000115957,0.0000452182,0.00033350836,0.0004763192,0.000019908322,0.10826182,0.008570551,0.0055268714],"study_design_scores_gemma":[0.0016686091,0.000023959796,0.029763492,0.000008820469,0.000013575535,0.000018145907,0.00005258756,0.036024947,0.000052167823,0.026858203,0.90477973,0.0007357635],"about_ca_topic_score_codex":0.32025513,"about_ca_topic_score_gemma":0.27377757,"teacher_disagreement_score":0.8962092,"about_ca_system_score_codex":0.001045867,"about_ca_system_score_gemma":0.00028392853,"threshold_uncertainty_score":0.999758},"labels":[],"label_agreement":null},{"id":"W4238629410","doi":"10.1007/s40274-014-1539-y","title":"Salmeterol/fluticasone cost effective in asthma in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Salmeterol; Fluticasone; Asthma; Quality of Life Research; Medicine; Public health; Internal medicine","score_opus":0.009858979572449989,"score_gpt":0.304686657059757,"score_spread":0.29482767748730704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238629410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934278,0.00022126503,0.000028680635,0.0028399515,0.00046789733,0.0011750994,0.000029863375,0.000023422986,0.0017859844],"genre_scores_gemma":[0.97316295,0.000040561823,0.000071294715,0.026267275,0.00012259072,0.00018055111,0.000016468233,0.00003611086,0.0001021967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984532,0.00013207582,0.00048408651,0.00036990052,0.000110374196,0.00045035637],"domain_scores_gemma":[0.9989365,0.0003490722,0.00010449095,0.0002621255,0.000020182726,0.00032766798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021745334,0.0002516761,0.00065775303,0.00018997077,0.000029171344,0.000016355078,0.000140663,0.000052202788,0.000226306],"category_scores_gemma":[0.00010396289,0.00022733345,0.000112494745,0.00011828791,0.000031671716,0.00010586587,0.000060110146,0.00029544276,0.00009773835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019589039,0.00010415584,0.90969706,0.0000436492,0.00003451083,0.00008001859,0.000040858085,0.00030584732,0.0002802477,0.00002770899,0.0024152116,0.08677482],"study_design_scores_gemma":[0.005522414,0.00006850186,0.8481185,0.00003348126,0.000031205243,0.000010785159,0.00010271074,0.003437148,0.0007982812,0.000021906751,0.14161304,0.00024202147],"about_ca_topic_score_codex":0.34513408,"about_ca_topic_score_gemma":0.74269426,"teacher_disagreement_score":0.39756018,"about_ca_system_score_codex":0.0011668327,"about_ca_system_score_gemma":0.0005898121,"threshold_uncertainty_score":0.92703897},"labels":[],"label_agreement":null},{"id":"W4238875952","doi":"10.1007/bf03276349","title":"Antibacterial use for outpatient CAP in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine; Nursing","score_opus":0.029828141058106942,"score_gpt":0.32263305937819003,"score_spread":0.2928049183200831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238875952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676615,0.000024600218,0.0000149984835,0.0005294902,0.0013055068,0.0008203052,0.00012198733,0.000013417634,0.00040354923],"genre_scores_gemma":[0.9912974,0.000033686647,0.0010957223,0.006601412,0.000052771356,0.00006496711,0.00007197883,0.000032810327,0.0007491982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988184,0.000028834831,0.00040649835,0.00028008485,0.00007187947,0.00039431025],"domain_scores_gemma":[0.99933636,0.00011675407,0.000101432495,0.00019933359,0.000027282791,0.00021882706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007206831,0.00020890235,0.0004494207,0.000076291464,0.000035472756,0.000023996363,0.00006428279,0.00003554282,0.00019387492],"category_scores_gemma":[0.000071557224,0.00018524361,0.00011628075,0.000037781807,0.000009611209,0.00013040409,0.000015940665,0.000105073,0.000025012736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119774784,0.00013726238,0.99506277,0.000022178943,0.00011433867,0.00008406852,0.000043372587,0.000038226208,0.00022804741,0.00009176977,0.0026983696,0.0013597931],"study_design_scores_gemma":[0.02024288,0.000223534,0.8730637,0.000013809844,0.00021891545,0.000022124395,0.0000655677,0.00027374577,0.008204302,0.00006339773,0.09735176,0.00025631255],"about_ca_topic_score_codex":0.30105418,"about_ca_topic_score_gemma":0.3915,"teacher_disagreement_score":0.121999145,"about_ca_system_score_codex":0.0009843748,"about_ca_system_score_gemma":0.0008032297,"threshold_uncertainty_score":0.75540155},"labels":[],"label_agreement":null},{"id":"W4239074657","doi":"10.1007/s40274-013-0260-6","title":"Insulin pump program funded in Alberta, Canada","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.020822101581167533,"score_gpt":0.33711628342389505,"score_spread":0.3162941818427275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239074657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90830415,0.00007169981,0.000001175693,0.050843623,0.00046114868,0.0019189061,0.0000038632684,0.000048877988,0.038346563],"genre_scores_gemma":[0.946786,0.000106928965,0.00029631887,0.021188097,0.00012864749,0.00039610852,0.00004873902,0.000043333966,0.031005817],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839205,0.000035745306,0.00045070515,0.00033695792,0.00016106134,0.0006234785],"domain_scores_gemma":[0.9991077,0.00015130427,0.000080965794,0.00030706648,0.00004024777,0.0003127044],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015247108,0.00021662764,0.000448313,0.00019117576,0.000040991883,0.00008420314,0.00025140744,0.00005181897,0.002464121],"category_scores_gemma":[0.0000489901,0.00018559626,0.000103118895,0.00015302812,0.000034486733,0.00021140452,0.00014211363,0.00030699442,0.0007910595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004706725,0.00035787057,0.71855414,0.000116533105,0.00021702317,0.000025742764,0.00006335821,0.000039098304,0.00009622637,0.0001931331,0.09177086,0.18851894],"study_design_scores_gemma":[0.005214137,0.0000882235,0.39266044,0.000019564737,0.000056795954,0.0000014594577,0.000108867294,0.007974184,0.00046429623,0.0002512843,0.59281963,0.0003411076],"about_ca_topic_score_codex":0.77981585,"about_ca_topic_score_gemma":0.7636453,"teacher_disagreement_score":0.5010488,"about_ca_system_score_codex":0.00039491057,"about_ca_system_score_gemma":0.00032807924,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W4239255913","doi":"10.1007/bf03279550","title":"Methylphenidate use low but rising among children in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Quality of Life Research; Psychology; Public health; Medicine; Psychiatry; Attention deficit hyperactivity disorder","score_opus":0.03755825418251017,"score_gpt":0.3154979730792761,"score_spread":0.2779397188967659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239255913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908659,0.00016925196,0.000044407185,0.006887476,0.00040808687,0.00057958625,0.000050599385,0.00005364296,0.0009410607],"genre_scores_gemma":[0.9833153,0.0002572607,0.00029958307,0.0140078105,0.00007814881,0.000022527658,0.000036110574,0.000065341046,0.0019179268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819404,0.00007272119,0.0006060718,0.00046270355,0.00016635408,0.00049812667],"domain_scores_gemma":[0.9988707,0.00021302716,0.00021306823,0.00041034445,0.000033818702,0.0002590598],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001250334,0.00030689267,0.0006496611,0.00019632344,0.000068157766,0.00006558916,0.0001677041,0.00006382631,0.0019825138],"category_scores_gemma":[0.00009672314,0.00031708906,0.00017011235,0.00014207645,0.000032813663,0.00060675514,0.00008295729,0.00046593742,0.00023483059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022687047,0.00012769148,0.98980296,0.0000139208505,0.00016434416,0.0000456231,0.00007827767,0.0007503375,0.00035499915,0.000012243382,0.004595752,0.0040311706],"study_design_scores_gemma":[0.003893187,0.000011491805,0.9817866,0.00002204245,0.00014179159,0.000037914808,0.00026171908,0.01026576,0.0004478059,0.000013582668,0.0027130381,0.00040506202],"about_ca_topic_score_codex":0.8228482,"about_ca_topic_score_gemma":0.74282587,"teacher_disagreement_score":0.08002234,"about_ca_system_score_codex":0.0009248246,"about_ca_system_score_gemma":0.00021986765,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W4239369968","doi":"10.1007/s40274-021-7452-2","title":"Early-phase trials used in reimbursement submissions in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Quality of Life Research; Phase (matter); Actuarial science; Business; Medicine; Public health; Political science; Chemistry; Nursing; Law; Health care","score_opus":0.4574671061897916,"score_gpt":0.5305500618397155,"score_spread":0.07308295564992395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239369968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88727266,0.0014358957,0.00011224637,0.10491649,0.0021649962,0.0010607236,0.0006631323,0.000028958206,0.0023449247],"genre_scores_gemma":[0.92951566,0.0006743515,0.0011162356,0.066567145,0.00028870517,0.00032339408,0.00013094708,0.00008290047,0.0013006859],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875153,0.0010363898,0.009421878,0.0010213134,0.00011586451,0.00088927307],"domain_scores_gemma":[0.9932108,0.0029296053,0.0025515181,0.0007889349,0.000044589287,0.00047455382],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.015095226,0.00041066628,0.0030081186,0.0005665975,0.00010900044,0.00012923969,0.00048909994,0.0001376394,0.0034370772],"category_scores_gemma":[0.0038633852,0.00053773704,0.00031091744,0.0003369896,0.000026481104,0.0005786234,0.00014151153,0.00046423593,0.0008035045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000517025,0.00038511545,0.9400185,0.00011867908,0.00016939208,0.000062929794,0.0010825745,0.001315187,0.0000550228,0.009768365,0.04605856,0.00091401406],"study_design_scores_gemma":[0.032349482,0.00007871577,0.45038518,0.00018269129,0.000056299366,0.000015128083,0.004943734,0.013839039,0.00061747874,0.011433398,0.4838285,0.00227033],"about_ca_topic_score_codex":0.8064763,"about_ca_topic_score_gemma":0.8930808,"teacher_disagreement_score":0.4896333,"about_ca_system_score_codex":0.0055207317,"about_ca_system_score_gemma":0.0031433231,"threshold_uncertainty_score":0.9999745},"labels":[],"label_agreement":null},{"id":"W4239490125","doi":"10.2165/00151234-200805520-00015","title":"COPD exacerbations exasperate costs in Canada","year":2008,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; COPD; Health economics; Medicine; Public health; Business; Nursing; Internal medicine","score_opus":0.027976318476197814,"score_gpt":0.3277751043964014,"score_spread":0.2997987859202036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239490125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783721,0.000687602,0.000007061604,0.0086321505,0.0005375681,0.00084996305,0.00013613445,0.000042949916,0.010734469],"genre_scores_gemma":[0.9843365,0.00085165515,0.00015936146,0.010406842,0.00016410367,0.000096832446,0.0000872514,0.000059452446,0.0038380122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796665,0.00007634724,0.00057531317,0.00049286126,0.00025068122,0.000638179],"domain_scores_gemma":[0.99863416,0.00019911489,0.00009858976,0.00044078706,0.00008217988,0.00054519257],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011956168,0.00028755647,0.00057346345,0.00021529672,0.00013006743,0.000019031411,0.00024161054,0.000050535677,0.0025216965],"category_scores_gemma":[0.000056669778,0.00029700305,0.00013491364,0.00021514064,0.00008646892,0.00022639845,0.0001186675,0.00042848583,0.0003160029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012260255,0.0001309406,0.964156,0.000056115165,0.00011021358,0.0005215263,0.000096971286,0.00033690673,0.00037127416,0.0001339658,0.029265342,0.004698175],"study_design_scores_gemma":[0.004932398,0.000016031612,0.94560564,0.000018306515,0.00004709281,0.00011344287,0.00024794776,0.0046958616,0.00069324556,0.00002685953,0.04327651,0.000326659],"about_ca_topic_score_codex":0.7585858,"about_ca_topic_score_gemma":0.7541811,"teacher_disagreement_score":0.018550325,"about_ca_system_score_codex":0.006579985,"about_ca_system_score_gemma":0.004994857,"threshold_uncertainty_score":0.9999482},"labels":[],"label_agreement":null},{"id":"W4239596802","doi":"10.1007/s40274-013-0638-5","title":"A quarter of US antibiotic prescriptions are not indicated","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medical prescription; Quality of Life Research; Antibiotics; Health economics; Public health; Medicine; Pharmacology; Microbiology; History; Nursing; Biology","score_opus":0.014088377768994423,"score_gpt":0.27487949035444886,"score_spread":0.26079111258545445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239596802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154806,0.00059156195,0.000044529756,0.004094876,0.0010239283,0.00042550502,0.000083297375,0.00006815978,0.0021200865],"genre_scores_gemma":[0.9911474,0.00021656652,0.00010632715,0.0043505677,0.00002798278,0.000007519644,0.00003877485,0.000022951486,0.0040819137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986884,0.00008320174,0.0005386467,0.00030450235,0.00002165915,0.00036357573],"domain_scores_gemma":[0.9991003,0.00009663005,0.00037386562,0.00033272844,0.000050433253,0.000046036927],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008155909,0.00021735571,0.0004990142,0.00013875199,0.00010579148,0.000022749855,0.00032728145,0.00016908937,0.0028075255],"category_scores_gemma":[0.000018521532,0.00018276417,0.00019262763,0.000071050265,0.00017170943,0.0001919236,0.00007484972,0.00024199579,0.0035934823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072343275,0.0004055993,0.49059093,0.00008759391,0.00078543474,0.0000030337762,0.00036136547,0.000017881066,0.40585646,0.0004869285,0.09989265,0.0014397773],"study_design_scores_gemma":[0.0033833757,0.0000829352,0.7273639,0.00005406968,0.00021456281,0.00001890986,0.0005692503,0.00006804032,0.2170852,0.00014093185,0.050521024,0.0004977957],"about_ca_topic_score_codex":0.0010739517,"about_ca_topic_score_gemma":0.000120685385,"teacher_disagreement_score":0.23677297,"about_ca_system_score_codex":0.000037451082,"about_ca_system_score_gemma":0.000043092732,"threshold_uncertainty_score":0.99810404},"labels":[],"label_agreement":null},{"id":"W4239998127","doi":"10.1007/s40274-018-4899-x","title":"Cost of living kidney donor care substantial in Canada","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Public health; Business; Medicine; Environmental health; Nursing","score_opus":0.02206480715044049,"score_gpt":0.32596959214293003,"score_spread":0.3039047849924895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239998127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201584,0.000048076774,0.000051972536,0.002854429,0.0007977618,0.0003280894,0.00012245054,0.00001541978,0.0037659828],"genre_scores_gemma":[0.9893563,0.00010794499,0.00019387608,0.010030455,0.00012178661,0.0000066269486,0.00003759194,0.000018388806,0.00012706993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991918,0.000020583533,0.00036816535,0.00016372284,0.000082557075,0.00017312932],"domain_scores_gemma":[0.99943954,0.00011376091,0.0001031159,0.00012179263,0.000064233696,0.00015753467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000063180116,0.00011221477,0.00027282306,0.00011259201,0.000026489137,0.000007811872,0.0000810418,0.000028011598,0.0012842836],"category_scores_gemma":[0.000047563997,0.00011323004,0.00005044497,0.00007919747,0.000025051873,0.000089292196,0.0000132346095,0.00009966074,0.000031671163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009366015,0.000027836812,0.99011594,0.0000997487,0.000050319733,0.00000957041,0.0014681641,0.000014555621,0.0017191464,0.000061632745,0.0026730937,0.0036663464],"study_design_scores_gemma":[0.004119208,0.00006055568,0.9167368,0.0001613013,0.00016044939,0.000015800404,0.0017658592,0.0012087172,0.044082418,0.0000063954208,0.03138363,0.0002988649],"about_ca_topic_score_codex":0.49649534,"about_ca_topic_score_gemma":0.8728859,"teacher_disagreement_score":0.37639058,"about_ca_system_score_codex":0.00047883287,"about_ca_system_score_gemma":0.0011751166,"threshold_uncertainty_score":0.99962866},"labels":[],"label_agreement":null},{"id":"W4240222421","doi":"10.1007/s40274-017-4497-3","title":"Costs of AMI high in Canada but decreasing","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Public health; Nursing","score_opus":0.05276754108564626,"score_gpt":0.3283007964239006,"score_spread":0.27553325533825435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240222421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552121,0.00026612164,0.00008644406,0.023027726,0.0014412293,0.0003317875,0.00030871487,0.000012345977,0.019313505],"genre_scores_gemma":[0.991042,0.0006005428,0.0003918932,0.00740992,0.00008594686,0.00002556003,0.000009375538,0.000029238357,0.00040548036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804646,0.000020988009,0.0010448984,0.00038845566,0.000031722113,0.00046745647],"domain_scores_gemma":[0.9981225,0.000105640436,0.00087668846,0.00069238385,0.000016276113,0.00018650244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004391622,0.00020270773,0.00070910703,0.00020064382,0.00014314498,0.00007773067,0.0006746424,0.000050597886,0.00025144377],"category_scores_gemma":[0.00014156975,0.0002529262,0.0001033386,0.000039800245,0.000039327497,0.00033184065,0.00020589474,0.00017472863,0.000116975134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022467986,0.00004344454,0.80219156,0.000052058513,0.00007982539,0.000012653653,0.00006817884,0.0001707045,0.000008186009,0.18424796,0.0016105756,0.011492396],"study_design_scores_gemma":[0.0032237025,0.000023231296,0.8394086,0.0000355987,0.000015780694,0.0000025259014,0.00018522459,0.003125384,0.0005533331,0.01273064,0.14004083,0.0006551538],"about_ca_topic_score_codex":0.9957077,"about_ca_topic_score_gemma":0.9664019,"teacher_disagreement_score":0.17151731,"about_ca_system_score_codex":0.0014573742,"about_ca_system_score_gemma":0.00034098612,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W4240472339","doi":"10.2165/00151234-200805570-00031","title":"Quebec has become the first Canadian province to reimburse the rivastigmine [Exelon] transdermal patch,","year":2008,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivastigmine; Business; Transdermal patch; Quality of Life Research; Medicine; Pharmacology; Public health; Transdermal; Nursing; Internal medicine","score_opus":0.14346386070170758,"score_gpt":0.3752627988071266,"score_spread":0.23179893810541902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240472339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88480955,0.00013033405,0.000050453396,0.110854074,0.0006208801,0.0007307098,0.00018079721,0.00011880602,0.0025043602],"genre_scores_gemma":[0.962812,0.000052570274,0.00026997563,0.03217444,0.0004948019,0.00010612143,0.000016993088,0.000069932954,0.0040031793],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794245,0.00010287834,0.0005468601,0.00052244443,0.00014228912,0.00074310723],"domain_scores_gemma":[0.99828506,0.00049799395,0.00017228076,0.0005844218,0.000043519034,0.00041671586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028331488,0.00041164685,0.00040744813,0.00011622895,0.0012758493,0.00016304152,0.0011409869,0.000058621663,0.00048121304],"category_scores_gemma":[0.000071007955,0.00026210182,0.00025004183,0.00012414731,0.00026534978,0.0002694871,0.00013519847,0.00045803937,0.00067939406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009698163,0.00032123004,0.6250619,0.000100463825,0.0009330891,0.001640407,0.027412904,0.0023550303,0.0012419957,0.0021887196,0.31152403,0.02625036],"study_design_scores_gemma":[0.00095454237,0.000192582,0.16601099,0.000019168245,0.00006777454,0.00028153017,0.00030986647,0.0019802288,0.0002563124,0.0000563665,0.8292889,0.0005817519],"about_ca_topic_score_codex":0.6848786,"about_ca_topic_score_gemma":0.80984557,"teacher_disagreement_score":0.51776487,"about_ca_system_score_codex":0.00034993785,"about_ca_system_score_gemma":0.00057830586,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W4241293564","doi":"10.1007/bf03280638","title":"Canadian government and Shire agree on 'flu vaccines","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Shire; Government (linguistics); Quality of Life Research; Virology; Public health; Public administration; Medicine; Political science; Geography; Archaeology; Philosophy","score_opus":0.02137698621031893,"score_gpt":0.32764423620432853,"score_spread":0.3062672499940096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241293564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8497255,0.0002368279,0.000003750778,0.08056501,0.00069415424,0.0002761208,0.000030031228,0.00006850092,0.068400085],"genre_scores_gemma":[0.95665544,0.002584961,0.000045417266,0.030077722,0.0004900585,0.000015866768,0.0000028638783,0.000030200896,0.01009747],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987704,0.00005273642,0.00024676695,0.00030066524,0.00013930668,0.0004901197],"domain_scores_gemma":[0.999077,0.00013307713,0.000083340106,0.00018594788,0.00001883484,0.00050174963],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002313146,0.00018238598,0.0002517445,0.00006927276,0.00038608865,0.00014539725,0.00026755437,0.0000679534,0.0010357172],"category_scores_gemma":[0.000047868936,0.00018159376,0.000090750626,0.00007539145,0.000009169898,0.00029951087,0.000040343693,0.00013565879,0.00020988421],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029322671,0.00003444971,0.8875076,0.000004638185,0.000058647976,0.000036545665,0.0015588553,0.000024211911,0.00002417714,0.006812689,0.07031866,0.033590168],"study_design_scores_gemma":[0.00074961595,0.000023130558,0.14518319,0.0000051036845,0.000029290484,0.0000023507394,0.0007701014,0.000067847046,0.000028608796,0.0007200696,0.85216784,0.0002528514],"about_ca_topic_score_codex":0.20131391,"about_ca_topic_score_gemma":0.78028226,"teacher_disagreement_score":0.7818492,"about_ca_system_score_codex":0.000747462,"about_ca_system_score_gemma":0.00021080072,"threshold_uncertainty_score":0.99987745},"labels":[],"label_agreement":null},{"id":"W4241570227","doi":"10.2165/00151234-201206580-00017","title":"Intrathecal analgesics worth it for chronic pain in Canada","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Intrathecal; Chronic pain; Medicine; Pain management; Anesthesia; Public health; Physical therapy; Nursing","score_opus":0.023261385635946593,"score_gpt":0.3230461119529087,"score_spread":0.2997847263169621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241570227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690835,0.00078917097,0.0009773503,0.024564344,0.0011520017,0.0012893324,0.000028942703,0.0000398909,0.0020754759],"genre_scores_gemma":[0.94940984,0.0003782981,0.000827277,0.047191545,0.0007060501,0.0001162595,0.00006440322,0.000043539458,0.0012627678],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985319,0.000051118484,0.00045415488,0.00022854666,0.00008837236,0.0006459314],"domain_scores_gemma":[0.99905705,0.00029602324,0.000110795074,0.0002454799,0.000016172042,0.0002744477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075050973,0.00021996291,0.0004411289,0.000117621494,0.000042417418,0.000018233206,0.00016537389,0.000041122676,0.00033506093],"category_scores_gemma":[0.00006829852,0.00020903905,0.00012899732,0.000090378184,0.000015075999,0.00016037299,0.000049784623,0.00019129389,0.000034739616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000703929,0.00007135998,0.8654281,0.00010067709,0.0001215579,0.0000067664905,0.00010041326,0.00010483195,0.000054159416,0.00035836012,0.10344571,0.030137701],"study_design_scores_gemma":[0.0041919546,0.000063636406,0.23514475,0.000021880418,0.00015493743,0.0000011271999,0.0002715977,0.014815767,0.00025470273,0.000080708814,0.74463993,0.00035901097],"about_ca_topic_score_codex":0.17328505,"about_ca_topic_score_gemma":0.6822382,"teacher_disagreement_score":0.6411942,"about_ca_system_score_codex":0.0016397067,"about_ca_system_score_gemma":0.0007393455,"threshold_uncertainty_score":0.8524365},"labels":[],"label_agreement":null},{"id":"W4242090716","doi":"10.1007/bf03275938","title":"IV PPI use warranted for GI haemorrhage in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health","score_opus":0.03915739238221776,"score_gpt":0.33871039163999234,"score_spread":0.29955299925777457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242090716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857792,0.0001799891,0.0002550533,0.009560431,0.0006935254,0.0013294548,0.00010073841,0.00003755459,0.0020640425],"genre_scores_gemma":[0.9704994,0.00011376563,0.0049890704,0.018321943,0.00011479731,0.00015176766,0.00005923623,0.00007119581,0.0056788446],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978973,0.00006752126,0.0006304406,0.00044204685,0.00016436189,0.0007983062],"domain_scores_gemma":[0.9986454,0.00046034224,0.00009885691,0.00035801335,0.000081676146,0.00035567427],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034138633,0.00029466307,0.0006993768,0.00018594203,0.00009329229,0.00004852859,0.00018869572,0.000080834514,0.0010051843],"category_scores_gemma":[0.0003561229,0.0002642885,0.00019915971,0.00014422096,0.00003011504,0.00024302573,0.00003648876,0.0004380925,0.00007862693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007086578,0.0002810318,0.90911096,0.00041548754,0.00022428086,0.0004969348,0.00027077142,0.00025413217,0.0042189006,0.0013623151,0.039626613,0.043029882],"study_design_scores_gemma":[0.046421047,0.00035275638,0.08279623,0.00009616612,0.00048312836,0.0005218506,0.0024041322,0.42693168,0.054714765,0.0008857439,0.38175938,0.0026331241],"about_ca_topic_score_codex":0.47418106,"about_ca_topic_score_gemma":0.6292194,"teacher_disagreement_score":0.82631475,"about_ca_system_score_codex":0.0012455983,"about_ca_system_score_gemma":0.001588553,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W4242511439","doi":"10.1007/bf03280586","title":"Newer neuropsychotherapeutic agents increase expenditure in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Public health; Medicine; Nursing","score_opus":0.2345095394759057,"score_gpt":0.4527698876803418,"score_spread":0.21826034820443613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242511439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8750496,0.0013061629,0.00019009593,0.10677493,0.0032458943,0.0009958539,0.0003034565,0.000066287044,0.012067719],"genre_scores_gemma":[0.7162974,0.00096860947,0.0003061406,0.2799437,0.00039679083,0.0001459142,0.00005016748,0.000098571756,0.0017927103],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932526,0.00032767683,0.0044560093,0.00095698127,0.0001040527,0.00090270827],"domain_scores_gemma":[0.9962381,0.0007514591,0.001693793,0.0007920722,0.00002595879,0.00049862853],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0030745417,0.0004634392,0.0014737906,0.0004531842,0.00014285745,0.000114367955,0.00072607386,0.00011927925,0.0050444715],"category_scores_gemma":[0.00032130754,0.00060224725,0.0002075535,0.00021656284,0.000033499946,0.000725174,0.00008245099,0.00042214978,0.0026392057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048196413,0.00011339162,0.86485475,0.000048921953,0.00011177317,0.000029436325,0.00043914482,0.0010866208,0.0000046614905,0.0034402495,0.12906055,0.00076226465],"study_design_scores_gemma":[0.003434318,0.000020556012,0.25658858,0.000020031097,0.000012922627,0.000022684533,0.0005127805,0.010222463,0.000005329493,0.003542404,0.72482234,0.0007956137],"about_ca_topic_score_codex":0.8630848,"about_ca_topic_score_gemma":0.81044185,"teacher_disagreement_score":0.60826623,"about_ca_system_score_codex":0.0030584058,"about_ca_system_score_gemma":0.0008474538,"threshold_uncertainty_score":0.9996429},"labels":[],"label_agreement":null},{"id":"W4242710605","doi":"10.1007/bf03278876","title":"Pioglitazone economically attractive for type 2 DM in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pioglitazone; Quality of Life Research; Public health; Type 2 diabetes; Medicine; Endocrinology","score_opus":0.04886457988781469,"score_gpt":0.3300135550347344,"score_spread":0.2811489751469197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242710605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96402323,0.00027965638,0.000012279724,0.016423471,0.0010312567,0.0012217049,0.00004992055,0.000034090503,0.016924378],"genre_scores_gemma":[0.9695685,0.00037296512,0.00088617584,0.021910489,0.00015478086,0.00013903498,0.000054847933,0.000046555815,0.006866686],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877226,0.000012791936,0.00041764206,0.0003388148,0.00005221321,0.0004062651],"domain_scores_gemma":[0.99926895,0.00017694173,0.00011235548,0.00023326864,0.000027455355,0.00018100666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000082327395,0.00022115611,0.000516953,0.00011264554,0.000039250168,0.000022377877,0.00012259715,0.000034331162,0.0011505653],"category_scores_gemma":[0.000024227602,0.00021337256,0.00012555333,0.00005579778,0.000014302428,0.00014889242,0.000043818953,0.000112049005,0.00021530298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039026176,0.00062456034,0.70431924,0.00012254389,0.001225196,0.00005619938,0.00023346285,0.0004438042,0.00027735493,0.0007843629,0.22553861,0.06598442],"study_design_scores_gemma":[0.015405717,0.0002898481,0.1144395,0.000024736994,0.0004961467,0.00000506306,0.00031305567,0.017709602,0.0012323093,0.00029533045,0.84912443,0.0006642413],"about_ca_topic_score_codex":0.19687267,"about_ca_topic_score_gemma":0.45730737,"teacher_disagreement_score":0.6235858,"about_ca_system_score_codex":0.0015729362,"about_ca_system_score_gemma":0.00019847833,"threshold_uncertainty_score":0.99976254},"labels":[],"label_agreement":null},{"id":"W4243068281","doi":"10.2165/00151234-201106200-00034","title":"Azacitidine reimbursed in Quebec, Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Azacitidine; Public health; Medicine; Chemistry; Nursing","score_opus":0.02704849171701705,"score_gpt":0.29306961876654736,"score_spread":0.2660211270495303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243068281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94283366,0.00015294964,0.000010475068,0.020560453,0.0006459464,0.0005791237,0.000016747781,0.00006143874,0.035139225],"genre_scores_gemma":[0.90909785,0.00017593919,0.0011643098,0.01409007,0.00008755502,0.000076411845,0.000073059935,0.000048816935,0.07518597],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986348,0.000025821637,0.0005031966,0.00033059804,0.00010344766,0.0004021039],"domain_scores_gemma":[0.9992974,0.000055605597,0.00010223196,0.0002617076,0.000024527311,0.00025856696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000098075536,0.00026503386,0.0005255563,0.00015908634,0.00003828848,0.000013024638,0.00013351247,0.000048815804,0.0019478683],"category_scores_gemma":[0.000015799742,0.00023543625,0.00010430676,0.00009531094,0.000022847484,0.00013105985,0.000046621597,0.00017694077,0.00020224508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018070765,0.0002401505,0.9023219,0.000029049734,0.00029777942,0.00038963664,0.000848487,0.0000038450703,0.00015925926,0.0002874459,0.088763535,0.006478207],"study_design_scores_gemma":[0.013331603,0.0000364139,0.42050797,0.000050968803,0.00028642145,0.00003081972,0.00059936644,0.0002700882,0.014688153,0.00019334187,0.54921967,0.0007851849],"about_ca_topic_score_codex":0.7944252,"about_ca_topic_score_gemma":0.9681824,"teacher_disagreement_score":0.4818139,"about_ca_system_score_codex":0.0008786842,"about_ca_system_score_gemma":0.0008792556,"threshold_uncertainty_score":0.9989645},"labels":[],"label_agreement":null},{"id":"W4243325939","doi":"10.2165/00151234-200404500-00044","title":"Medical association welcomes Canadian govt funding initiative","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Association (psychology); Public health; Library science; Political science; Medicine; Computer science; Nursing; Psychology","score_opus":0.0713932492317379,"score_gpt":0.40974690017593984,"score_spread":0.33835365094420194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243325939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7244365,0.00017959291,0.00017263723,0.2113837,0.0013718838,0.00046537546,0.000082095794,0.00015946409,0.061748702],"genre_scores_gemma":[0.82951754,0.00034149043,0.00017940556,0.16898473,0.0004864296,0.000024685502,0.000033976157,0.000033808814,0.0003979311],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977526,0.00008316385,0.0006518383,0.00035986968,0.00039241713,0.0007601069],"domain_scores_gemma":[0.9979805,0.00039140592,0.00020198377,0.0001835108,0.00008769354,0.0011549467],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009972724,0.0002606398,0.0005518309,0.00020786715,0.0002019661,0.00007631902,0.00022241916,0.00021968571,0.0027353049],"category_scores_gemma":[0.0005516379,0.00025881137,0.00024023103,0.00014067737,0.000043911434,0.00032612056,0.0000668472,0.00076612027,0.0012485333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025370924,0.0004930384,0.9196747,0.00021905241,0.0019311756,0.0005148942,0.0026355938,0.000170855,0.00087364414,0.026756478,0.020030875,0.026445983],"study_design_scores_gemma":[0.027724145,0.00023118316,0.13048266,0.000326611,0.0010023299,0.0002583664,0.0023085885,0.0029447584,0.010728432,0.00763652,0.8145473,0.0018091417],"about_ca_topic_score_codex":0.019293861,"about_ca_topic_score_gemma":0.028167283,"teacher_disagreement_score":0.7945164,"about_ca_system_score_codex":0.0029207137,"about_ca_system_score_gemma":0.0014243559,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W4243610834","doi":"10.1007/s40274-013-0885-5","title":"Economic impact of introducing dimethyl fumarate into Canada","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Chemical Synthesis and Reactions","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dimethyl fumarate; Quality of Life Research; Chemistry; Public health; Medicine","score_opus":0.007919565342639892,"score_gpt":0.29460752684037295,"score_spread":0.28668796149773307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243610834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880756,0.00009865269,0.000003963685,0.0025199472,0.00038044984,0.00009723284,0.00006506796,0.000033244803,0.008725855],"genre_scores_gemma":[0.99734485,0.0001303355,0.00020099389,0.00054758706,0.00029791179,0.00003518302,0.000026194803,0.00004088643,0.0013760348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857426,0.000013312263,0.0006371833,0.0003620871,0.000059227048,0.00035395217],"domain_scores_gemma":[0.9986699,0.00030572375,0.00032127366,0.0004205601,0.000029838568,0.00025268222],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007388123,0.00027424647,0.0005384237,0.000048671845,0.00007416215,0.000051341114,0.00034164524,0.00007577621,0.014041152],"category_scores_gemma":[0.000035979374,0.0002327177,0.00034416534,0.000030885258,0.00004167974,0.0002298019,0.000109369525,0.0002265975,0.00022942331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025632526,0.0000686452,0.105693944,0.00007456953,0.00079571636,0.0000012909109,0.0001136443,0.0032260418,0.7554606,0.000044002147,0.10843433,0.02606158],"study_design_scores_gemma":[0.00170537,0.000015534462,0.014805356,0.000022658893,0.0001736746,0.000010923252,0.00022803782,0.007606709,0.8771041,0.0006376814,0.09670747,0.0009824546],"about_ca_topic_score_codex":0.8862477,"about_ca_topic_score_gemma":0.14368643,"teacher_disagreement_score":0.7425613,"about_ca_system_score_codex":0.0018057859,"about_ca_system_score_gemma":0.00068794517,"threshold_uncertainty_score":0.98686016},"labels":[],"label_agreement":null},{"id":"W4244148411","doi":"10.1007/s40274-013-0929-x","title":"Crizotinib effective but too costly in Canada and the US","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crizotinib; Quality of Life Research; Public health; Medicine; Lung cancer; Oncology","score_opus":0.00763180274617116,"score_gpt":0.316984452600487,"score_spread":0.3093526498543159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244148411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686945,0.0003231815,0.000003831562,0.024018165,0.00040016804,0.0015644967,0.000026976957,0.000012420644,0.004956248],"genre_scores_gemma":[0.96031576,0.00018936917,0.00007561147,0.037924223,0.000055663168,0.00038466367,0.000011473824,0.000016759037,0.0010264739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992618,0.000042757667,0.00024264745,0.00019083201,0.00005447946,0.00020751073],"domain_scores_gemma":[0.9992876,0.00033649092,0.00007148988,0.0001530348,0.000026710579,0.00012466226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007422872,0.00014302149,0.0003378394,0.000040451854,0.000055123837,0.000032931082,0.00006572875,0.000019345263,0.0002411792],"category_scores_gemma":[0.000026929723,0.00009066615,0.000056012606,0.000038833532,0.00004335195,0.000111077235,0.000034123725,0.00013564412,0.000052134128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012630761,0.00004306122,0.9556363,0.000023992185,0.00035651657,0.000014996944,0.0004198521,0.00006881504,0.000090138645,0.00026114914,0.015788779,0.02717006],"study_design_scores_gemma":[0.017583465,0.00003936471,0.9498948,0.000012597887,0.00031879748,0.00002374242,0.0004302047,0.0015227807,0.00050390814,0.00027156319,0.029217042,0.00018172449],"about_ca_topic_score_codex":0.95845467,"about_ca_topic_score_gemma":0.75927955,"teacher_disagreement_score":0.19917507,"about_ca_system_score_codex":0.00073132804,"about_ca_system_score_gemma":0.00048481493,"threshold_uncertainty_score":0.36972582},"labels":[],"label_agreement":null},{"id":"W4244536565","doi":"10.2165/00151234-200404610-00013","title":"Fibromyalgia exacts substantial costs in Canada","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Fibromyalgia; Health economics; Public health; Business; Economics; Psychology; Medicine; Psychiatry; Nursing","score_opus":0.3368159591054161,"score_gpt":0.5178121967040649,"score_spread":0.18099623759864875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244536565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9247129,0.0002436867,0.00003282182,0.06510649,0.004061546,0.0012452322,0.00012671096,0.00009120572,0.0043794364],"genre_scores_gemma":[0.9306749,0.0005519704,0.00039283358,0.067487806,0.0002613174,0.0001263473,0.000040911596,0.00007864672,0.00038523506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504405,0.0010166066,0.0016903473,0.00062895915,0.00026928968,0.0013507382],"domain_scores_gemma":[0.995676,0.00226286,0.0007138036,0.00058463623,0.00010217724,0.0006605397],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00137155,0.00039792852,0.0007885947,0.0001953715,0.00040381716,0.00002948953,0.0005718712,0.00018877332,0.001452866],"category_scores_gemma":[0.0005332122,0.0004152452,0.00010473356,0.00022254034,0.00003923226,0.00069789845,0.00021386989,0.0015433435,0.0011173988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00018963567,0.00009330237,0.9764405,0.00048450555,0.00007820354,0.00011257456,0.001981522,0.00027453908,0.00022474414,0.0023934739,0.013934351,0.0037926417],"study_design_scores_gemma":[0.014574184,0.00006801988,0.7111154,0.00043415106,0.00008326302,0.000012787993,0.009261558,0.00022253435,0.00082012935,0.0012461421,0.2606472,0.001514614],"about_ca_topic_score_codex":0.98751175,"about_ca_topic_score_gemma":0.99489665,"teacher_disagreement_score":0.2653251,"about_ca_system_score_codex":0.010511129,"about_ca_system_score_gemma":0.015149553,"threshold_uncertainty_score":0.99982995},"labels":[],"label_agreement":null},{"id":"W4244584981","doi":"10.1007/s40274-017-3697-1","title":"Quadrivalent ACWY vaccine not cost effective in Quebec","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Public health; Medicine; Nursing","score_opus":0.027992058155788483,"score_gpt":0.3950212222470871,"score_spread":0.3670291640912986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244584981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651648,0.00015811292,0.000017230268,0.029453779,0.00081569084,0.0015542901,0.000046030782,0.00005598512,0.0027341181],"genre_scores_gemma":[0.97120035,0.0002642513,0.000054512755,0.024846734,0.00024410333,0.0002550293,0.00002771004,0.000034472967,0.0030728267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861467,0.000068530244,0.00041678088,0.00042845527,0.00007013401,0.00040143204],"domain_scores_gemma":[0.9986392,0.00016726031,0.0002413296,0.0006649489,0.000025367888,0.00026185164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020476403,0.00027850433,0.00068124884,0.0001398314,0.0001904179,0.00006412552,0.00033612558,0.000109500514,0.0005939822],"category_scores_gemma":[0.00017727335,0.0002467001,0.0002460777,0.00002345602,0.00007029915,0.0003676594,0.00016655128,0.00034133933,0.0007068553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012164819,0.00028865167,0.94255674,0.000053772965,0.0001977623,0.000098376244,0.0001199078,0.000027662381,0.001800517,0.00028249354,0.0066375975,0.046720047],"study_design_scores_gemma":[0.008409386,0.00008427023,0.94483244,0.000024595927,0.000189257,0.000007782166,0.000032714626,0.0004773158,0.0031168587,0.000088650566,0.04250552,0.00023120563],"about_ca_topic_score_codex":0.009706792,"about_ca_topic_score_gemma":0.016834553,"teacher_disagreement_score":0.04648884,"about_ca_system_score_codex":0.00026591102,"about_ca_system_score_gemma":0.00010025616,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W4244772948","doi":"10.1007/bf03275753","title":"Healthcare spending soars in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health care; Business; Health economics; Economics; Public health; Nursing; Medicine; Economic growth","score_opus":0.06540893024274555,"score_gpt":0.33228857306526643,"score_spread":0.26687964282252086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244772948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77074283,0.0026938189,0.00030215248,0.11618863,0.005679534,0.0012497583,0.00039929894,0.000082158986,0.10266182],"genre_scores_gemma":[0.9585191,0.00077167887,0.0004016879,0.03933003,0.0000670751,0.00005596311,0.000011378603,0.000044120286,0.0007989711],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973482,0.000055438526,0.001194339,0.0005622887,0.000036857113,0.00080286985],"domain_scores_gemma":[0.9988396,0.00010517237,0.00035638388,0.00038742612,0.000009241251,0.00030214377],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063504546,0.0002686445,0.00068387354,0.00032167468,0.00009758736,0.000052614356,0.0003235189,0.00005947584,0.0009151502],"category_scores_gemma":[0.00007573523,0.00034442454,0.000119680946,0.00018505457,0.000014811846,0.00025214034,0.00006624423,0.0003038707,0.0005758749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005548296,0.000026793154,0.58441514,0.000053690557,0.000038769642,0.000015680447,0.0001561461,0.00028153643,0.0000010079543,0.40839905,0.0047941976,0.0018124265],"study_design_scores_gemma":[0.0015241642,0.000015155013,0.052536953,0.000010106449,0.0000049098926,0.0000047546678,0.00039152225,0.0007646364,0.000077013945,0.019523606,0.924583,0.00056414434],"about_ca_topic_score_codex":0.9749537,"about_ca_topic_score_gemma":0.96873236,"teacher_disagreement_score":0.91978884,"about_ca_system_score_codex":0.0025800718,"about_ca_system_score_gemma":0.0004829754,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W4244986734","doi":"10.2165/00151234-200905850-00020","title":"Untreated maternal depression costly in Canada","year":2009,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Depression (economics); Psychiatry; Public health; Medicine; Psychology; Economics; Nursing; Keynesian economics","score_opus":0.015624205610984244,"score_gpt":0.3283844411967805,"score_spread":0.31276023558579624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244986734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880583,0.00034803795,0.0000019681477,0.0075323074,0.00066999,0.00039210872,0.000025376807,0.00003424331,0.002937612],"genre_scores_gemma":[0.9633456,0.00032228095,0.000080000485,0.03520867,0.00006931605,0.000012896601,0.000017962031,0.000015984377,0.0009273315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987547,0.000032052012,0.00047102993,0.00024791993,0.00010327426,0.00039106587],"domain_scores_gemma":[0.9993661,0.000042462776,0.000112885675,0.00018959785,0.000012527929,0.00027641232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000752624,0.00019000206,0.0003854209,0.00008331552,0.000041367515,0.00001561947,0.00011980835,0.000039260314,0.00044241262],"category_scores_gemma":[0.000006114967,0.00016620052,0.00005560591,0.000045622644,0.0000067801247,0.00010112031,0.000025497091,0.0002166027,0.00008044789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000468685,0.000044444805,0.99012476,0.00013832541,0.000017855626,0.00018878334,0.000043666947,0.000053037642,0.00023818579,0.000021969401,0.0009895567,0.007670701],"study_design_scores_gemma":[0.0033156904,0.000050650193,0.974699,0.0003669494,0.000026534872,0.00007624132,0.000018012748,0.00052431185,0.015547087,0.00006304146,0.0051425546,0.0001698935],"about_ca_topic_score_codex":0.6950602,"about_ca_topic_score_gemma":0.40732065,"teacher_disagreement_score":0.28773955,"about_ca_system_score_codex":0.00084851397,"about_ca_system_score_gemma":0.00039980232,"threshold_uncertainty_score":0.67774606},"labels":[],"label_agreement":null},{"id":"W4245178157","doi":"10.2165/00151234-200905870-00028","title":"According to the Royal Pharmaceutical Society of Great Britain, at least a quarter of patients with heart disease do not take vital medicines they have been prescribed","year":2009,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Quality of Life Research; Health economics; Public health; History; Nursing","score_opus":0.049151494112189296,"score_gpt":0.371596385363541,"score_spread":0.32244489125135173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245178157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92754513,0.00017870024,0.000064309475,0.0690278,0.00032983493,0.001851632,0.00030828462,0.000045305158,0.0006490331],"genre_scores_gemma":[0.93948805,0.0000399159,0.00035748142,0.05944553,0.00022967199,0.000035214227,0.000064977634,0.000046122324,0.00029300735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715745,0.00013323416,0.0009537475,0.00056087476,0.00053787016,0.00065684016],"domain_scores_gemma":[0.99745184,0.0005856593,0.00039148948,0.0005331338,0.00020078193,0.00083709945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043343994,0.00047118872,0.0010101118,0.00010121377,0.0001394056,0.000047784313,0.00036675055,0.00007920054,0.00042552923],"category_scores_gemma":[0.00012638554,0.00030045357,0.00053328526,0.00009270499,0.00015292628,0.00030080622,0.00018360947,0.00044365384,0.000043595264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006752987,0.00066132296,0.9716772,0.00016516657,0.00042415102,0.0000055075666,0.0010079335,0.00031977068,0.00056195504,0.000035109417,0.014922475,0.0034664632],"study_design_scores_gemma":[0.019513702,0.0012645911,0.8558524,0.00017815107,0.0025206478,0.000009845604,0.0010037441,0.009460117,0.0025164052,0.00005826816,0.106838085,0.00078399834],"about_ca_topic_score_codex":0.00011129921,"about_ca_topic_score_gemma":0.000024116129,"teacher_disagreement_score":0.115824714,"about_ca_system_score_codex":0.00018882316,"about_ca_system_score_gemma":0.00011725729,"threshold_uncertainty_score":0.99994475},"labels":[],"label_agreement":null},{"id":"W4245476379","doi":"10.2165/00151234-201206680-00033","title":"A report released by the Canadian Diabetes Association (CDA) recommends that Canada's drug review process be enhanced to ensure wider drug access.","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Quality of Life Research; Process (computing); Association (psychology); Business; Public health; Medicine; Pharmacology; Computer science; Psychology; Nursing","score_opus":0.048734976936854205,"score_gpt":0.43756325615396463,"score_spread":0.38882827921711044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245476379","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17212407,0.005262653,0.0000030900449,0.79053843,0.0054840897,0.003235721,0.00061148475,0.0001251988,0.022615237],"genre_scores_gemma":[0.30914658,0.0023604904,0.000036531877,0.67190754,0.0004919142,0.0010441348,0.0003533955,0.000086460714,0.014572918],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99423504,0.00084741035,0.0016125761,0.00060896995,0.0005091214,0.0021869019],"domain_scores_gemma":[0.99390274,0.0019842198,0.0014410912,0.00083267124,0.00032371088,0.0015155404],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036751514,0.0005420195,0.0011884095,0.00015264339,0.0017187318,0.000080768834,0.0010371188,0.00019616021,0.0021227095],"category_scores_gemma":[0.00093249977,0.00043435002,0.00022598573,0.00032411955,0.00002303395,0.0007895708,0.00023616801,0.0013720855,0.00018771604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000006956789,0.0000151014665,0.41654015,0.00040623738,0.00009334333,0.0000018719134,0.0005632188,0.000001142007,0.0000058501582,0.0000073253777,0.58082163,0.0015371785],"study_design_scores_gemma":[0.00067622046,0.0000049136243,0.057587974,0.00014978187,0.00018644493,0.000001529261,0.00032255953,0.0000052038554,0.00036324462,0.000033811953,0.94017047,0.00049784646],"about_ca_topic_score_codex":0.9217569,"about_ca_topic_score_gemma":0.9913386,"teacher_disagreement_score":0.35934883,"about_ca_system_score_codex":0.010267246,"about_ca_system_score_gemma":0.009687565,"threshold_uncertainty_score":0.9998108},"labels":[],"label_agreement":null},{"id":"W4246410034","doi":"10.2165/00151234-201106250-00034","title":"Investigation into Herceptin funding in Ontario","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Vitamin K Research Studies","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine; Nursing","score_opus":0.13310672145570052,"score_gpt":0.37143286128963104,"score_spread":0.23832613983393053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246410034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557186,0.00005876806,0.000013960664,0.0041148807,0.001300492,0.00043136574,0.0000025048278,0.00008807106,0.008418118],"genre_scores_gemma":[0.98961526,0.000025057536,0.0030869206,0.0056560114,0.00008505349,0.00007440428,0.0000103559505,0.000045649987,0.0014013094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818474,0.00011849835,0.0005510272,0.00043343683,0.00012290812,0.0005894065],"domain_scores_gemma":[0.9991715,0.00017095615,0.00015025462,0.00027249655,0.00003155487,0.00020323657],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053144025,0.0002631385,0.00040510186,0.00032583182,0.00014260695,0.00006255544,0.00035090576,0.000072614734,0.0009386772],"category_scores_gemma":[0.00010333028,0.0002704438,0.00011858159,0.0001240371,0.00009966133,0.0005694317,0.00019716512,0.0004968104,0.00052695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009231693,0.000040582592,0.9633046,0.000023399336,0.000048588154,0.0000072951048,0.02341904,0.000020629685,0.0028427294,0.00010792597,0.004038734,0.0060542086],"study_design_scores_gemma":[0.0022482567,0.0000901148,0.96245205,0.00002873252,0.000039475304,0.0000031958095,0.001631816,0.0004379342,0.011029807,0.004517586,0.017028278,0.00049272494],"about_ca_topic_score_codex":0.2673866,"about_ca_topic_score_gemma":0.5829288,"teacher_disagreement_score":0.31554222,"about_ca_system_score_codex":0.0017623963,"about_ca_system_score_gemma":0.00008848474,"threshold_uncertainty_score":0.9999748},"labels":[],"label_agreement":null},{"id":"W4246418223","doi":"10.1007/bf03278957","title":"Infliximab not worth it in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Infliximab; Quality of Life Research; Medicine; Public health; Internal medicine; Nursing; Tumor necrosis factor alpha","score_opus":0.031419871673688315,"score_gpt":0.31626177457414867,"score_spread":0.28484190290046035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246418223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92096454,0.00022240666,0.0000036362133,0.059243,0.00077866187,0.00048393133,0.000041721654,0.000032680193,0.01822944],"genre_scores_gemma":[0.8903045,0.00036777853,0.00024749833,0.10230541,0.00012954528,0.0000353799,0.0000107221385,0.000035268677,0.0065638633],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984297,0.000024643514,0.00060297834,0.00034638992,0.000115453615,0.00048082086],"domain_scores_gemma":[0.99910444,0.00012363691,0.000113230235,0.00037148801,0.00002140841,0.00026580773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000082345265,0.00023062593,0.0005590437,0.0001299193,0.00003233129,0.000023168244,0.00018630768,0.000044940145,0.0076083145],"category_scores_gemma":[0.000040822237,0.00024105603,0.00010095753,0.00009893525,0.000029269442,0.00011228142,0.00008178573,0.0003090785,0.00035159575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053859654,0.00008239483,0.84050983,0.000053090913,0.000080537626,0.00016722531,0.00030532447,0.000048976697,0.0004274332,0.000101613725,0.14236622,0.01580351],"study_design_scores_gemma":[0.007760403,0.000030356727,0.19903114,0.00003576259,0.000075477925,0.00006266398,0.00021272384,0.0041873734,0.0019713596,0.00001826492,0.7861732,0.00044125007],"about_ca_topic_score_codex":0.8568491,"about_ca_topic_score_gemma":0.9610917,"teacher_disagreement_score":0.643807,"about_ca_system_score_codex":0.0016649369,"about_ca_system_score_gemma":0.0005410707,"threshold_uncertainty_score":0.9932989},"labels":[],"label_agreement":null},{"id":"W4246761610","doi":"10.1007/s40274-021-7755-3","title":"Weekly rifapentine + isoniazid for latent TB infections saves costs in Nunavut, Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rifapentine; Isoniazid; Quality of Life Research; Medicine; Latent tuberculosis; Public health; Environmental health; Tuberculosis; Mycobacterium tuberculosis","score_opus":0.03145654159372338,"score_gpt":0.37539017667699887,"score_spread":0.34393363508327546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246761610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8334479,0.00053676986,0.0000614559,0.16211689,0.000924049,0.00067099853,0.00013579268,0.000035280023,0.0020709177],"genre_scores_gemma":[0.91124994,0.001983634,0.0007837574,0.07976178,0.0003587875,0.00027498498,0.00029079142,0.000059076294,0.0052372725],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800146,0.00011006508,0.0006563434,0.00044924818,0.00009529168,0.00068759726],"domain_scores_gemma":[0.9983601,0.0007154732,0.00011084897,0.00031222074,0.00010657243,0.0003947606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003400569,0.00023000129,0.00073046354,0.00014708455,0.00009187268,0.00002826454,0.00013148575,0.00008359439,0.0006823341],"category_scores_gemma":[0.0005717355,0.00022027834,0.00023251366,0.00014325554,0.000032459793,0.00010980379,0.00010071178,0.000369904,0.00007553873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012320628,0.00024336425,0.81067544,0.00006923439,0.00028930668,0.00006845543,0.00003130248,0.00021968072,0.0021340626,0.00032867628,0.18111409,0.004703207],"study_design_scores_gemma":[0.005990473,0.00010175544,0.33819008,0.000028294171,0.000112400616,0.000085498825,0.000105156316,0.0044494625,0.0031251814,0.00014954442,0.6473629,0.00029922882],"about_ca_topic_score_codex":0.29117334,"about_ca_topic_score_gemma":0.85189193,"teacher_disagreement_score":0.56071854,"about_ca_system_score_codex":0.0010273451,"about_ca_system_score_gemma":0.0012533239,"threshold_uncertainty_score":0.89826894},"labels":[],"label_agreement":null},{"id":"W4247730375","doi":"10.2165/00151234-201005990-00027","title":"Seek and Treat to kick off in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine","score_opus":0.02739122967409572,"score_gpt":0.41961702696753395,"score_spread":0.3922257972934382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247730375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88488364,0.000111554815,0.0000027458645,0.093056,0.0026502183,0.0008390172,0.00012815684,0.000044269313,0.0182844],"genre_scores_gemma":[0.54242784,0.00044655547,0.00054971926,0.45075965,0.00035707484,0.00012569882,0.000021187774,0.000058282745,0.005253994],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976261,0.0001285398,0.00085622637,0.00043149194,0.000102975224,0.00085462944],"domain_scores_gemma":[0.99793535,0.0008497426,0.00017204424,0.00038482275,0.00003993006,0.00061812176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038866609,0.00027813172,0.0006559251,0.00018655411,0.00027125352,0.000014772387,0.00030084356,0.000116088864,0.0016402964],"category_scores_gemma":[0.0000820311,0.00025978664,0.00005960958,0.00010936271,0.000018967517,0.00019182963,0.00023263127,0.0010203362,0.0003893269],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004747907,0.000014453093,0.7972825,0.000070206595,0.0000151238655,0.000013490306,0.0006982297,0.000006103119,0.0003484074,0.00032609463,0.18070166,0.020476244],"study_design_scores_gemma":[0.0016121297,0.000012129294,0.3492311,0.0000062561726,0.000015321852,0.000002247687,0.0004955476,0.0000743417,0.00005884257,0.00013813532,0.64810705,0.00024691335],"about_ca_topic_score_codex":0.8926222,"about_ca_topic_score_gemma":0.995798,"teacher_disagreement_score":0.46740538,"about_ca_system_score_codex":0.0016137598,"about_ca_system_score_gemma":0.0050437828,"threshold_uncertainty_score":0.99998546},"labels":[],"label_agreement":null},{"id":"W4248226877","doi":"10.2165/00151234-201006080-00020","title":"Hypoglycaemia exacts extra costs in Canada","year":2010,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Services Management and Policy","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Health economics; Economics; Public health; Medicine; Nursing","score_opus":0.04313908097705882,"score_gpt":0.4395245993307293,"score_spread":0.3963855183536705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248226877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89082223,0.00003455599,0.0000022861236,0.03278129,0.005621874,0.001019869,0.000047447076,0.00006255373,0.069607906],"genre_scores_gemma":[0.8127857,0.00018734903,0.0001864144,0.18230844,0.0006493511,0.00015944177,0.00003235869,0.00005259176,0.0036383877],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971006,0.00019894946,0.0010442685,0.00039109177,0.00013038705,0.0011347152],"domain_scores_gemma":[0.99779993,0.0007944071,0.0003588068,0.0004927956,0.00003799363,0.00051607133],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006317768,0.00029131633,0.0005191718,0.00019637165,0.0002872765,0.000018368444,0.00056786725,0.0001377491,0.0040131803],"category_scores_gemma":[0.000058491627,0.00028952915,0.00006716,0.00015927495,0.00001616526,0.00029048516,0.00020895239,0.001512022,0.0014218269],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035872516,0.000026001131,0.8810119,0.00016440604,0.000024809564,0.000015386951,0.0005818334,0.000019765454,0.00017411099,0.0018025236,0.10305748,0.013085909],"study_design_scores_gemma":[0.0018691245,0.0000051378,0.30273134,0.00001730444,0.0000135106575,5.534913e-7,0.00054666575,0.00076243695,0.000023222587,0.00013751967,0.69362414,0.0002690363],"about_ca_topic_score_codex":0.9832561,"about_ca_topic_score_gemma":0.99835116,"teacher_disagreement_score":0.5905667,"about_ca_system_score_codex":0.0015691937,"about_ca_system_score_gemma":0.0031187963,"threshold_uncertainty_score":0.9999557},"labels":[],"label_agreement":null},{"id":"W4249070868","doi":"10.2165/00151234-200404670-00014","title":"Additional pertussis booster warranted among Canadian teens","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Booster (rocketry); Quality of Life Research; Medicine; Pediatrics; Public health","score_opus":0.016505900574232322,"score_gpt":0.3268944248113092,"score_spread":0.31038852423707686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249070868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8884819,0.000050408435,0.000046955072,0.04209509,0.00043145646,0.000981528,0.0048013283,0.00010314157,0.06300818],"genre_scores_gemma":[0.94144726,0.00006441806,0.00039746077,0.045927722,0.0002655349,0.00019660992,0.0023770693,0.00005205667,0.009271851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984165,0.000028703562,0.000346395,0.00037354903,0.00018610925,0.0006487577],"domain_scores_gemma":[0.9986776,0.000108812914,0.00006785082,0.00021328309,0.00009573919,0.0008367012],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000119642595,0.00023808239,0.00034467576,0.00034722846,0.00016802087,0.00007035175,0.00015423557,0.00007224289,0.1160241],"category_scores_gemma":[0.0000678299,0.00021412646,0.0002534511,0.00010362649,0.00009493547,0.00024822366,0.000049352988,0.00029614574,0.0020145364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012680316,0.0002470586,0.6518231,0.00004133382,0.00057091116,0.0002535155,0.00020528691,0.000013822987,0.0003807758,0.0001315657,0.3359479,0.010257928],"study_design_scores_gemma":[0.0047118124,0.00009468803,0.59341955,0.000038786984,0.00011860812,0.00004895217,0.00016027973,0.0001411296,0.0009607603,0.00016813337,0.39985633,0.00028097146],"about_ca_topic_score_codex":0.027100896,"about_ca_topic_score_gemma":0.04740267,"teacher_disagreement_score":0.11400957,"about_ca_system_score_codex":0.0006179718,"about_ca_system_score_gemma":0.00068878697,"threshold_uncertainty_score":0.9987625},"labels":[],"label_agreement":null},{"id":"W4249484723","doi":"10.2165/00151234-200504770-00015","title":"Osteoporosis treatment suboptimal in Canada","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Osteoporosis; Medicine; Public health; Internal medicine; Pathology","score_opus":0.018393757534471953,"score_gpt":0.3015883457465346,"score_spread":0.2831945882120626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249484723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9364496,0.00016387479,0.000006415652,0.04434483,0.00049424905,0.00034977615,0.000020511146,0.00003554255,0.018135238],"genre_scores_gemma":[0.9480841,0.00025571953,0.0007021575,0.04707188,0.00013837226,0.000037037065,0.000031519667,0.000027058342,0.0036521128],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989788,0.000016405254,0.00037358087,0.0002579383,0.000070563096,0.0003026924],"domain_scores_gemma":[0.9994359,0.000052514923,0.00007010088,0.00020244971,0.000013171371,0.00022587126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005015557,0.00019409915,0.00037457477,0.00010591777,0.00003185136,0.0000149113675,0.00006498198,0.00003260264,0.0029156164],"category_scores_gemma":[0.000009456349,0.00017458764,0.00011388841,0.00006627103,0.000011373857,0.00010688998,0.000017822058,0.00010217619,0.00027609474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019996836,0.00019568842,0.9186418,0.000008035717,0.000105406245,0.00002076424,0.00017986374,0.0013615461,0.00011865834,0.00006311428,0.024327122,0.054778025],"study_design_scores_gemma":[0.013505819,0.00010087587,0.16920903,0.0000050142626,0.0001259364,0.000033025794,0.00074174127,0.004709578,0.0010470008,0.000010866996,0.8101894,0.0003216892],"about_ca_topic_score_codex":0.75655645,"about_ca_topic_score_gemma":0.9348718,"teacher_disagreement_score":0.7858623,"about_ca_system_score_codex":0.0021629157,"about_ca_system_score_gemma":0.0010741596,"threshold_uncertainty_score":0.99799585},"labels":[],"label_agreement":null},{"id":"W4249515208","doi":"10.2165/00151234-200404530-00026","title":"Canadian funding praised by WHO, drugs bill to be approved","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Political science; Medicine; Public health","score_opus":0.036562466683443595,"score_gpt":0.3371623758934032,"score_spread":0.3005999092099596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249515208","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23617509,0.000041062845,0.000102273516,0.72520995,0.0016053212,0.00065302424,0.000070562965,0.00014224956,0.03600045],"genre_scores_gemma":[0.22136614,0.00003543746,0.0002206865,0.77626944,0.00088527246,0.000067007015,0.00008555865,0.000053949567,0.0010165074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973188,0.00001950718,0.0006957664,0.000513378,0.000091183756,0.0013613406],"domain_scores_gemma":[0.99888664,0.00009666313,0.00026829052,0.0003313962,0.00006696061,0.0003500606],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069530454,0.00034749176,0.00059599517,0.00042784165,0.00033005068,0.0002943596,0.0005755946,0.000120486155,0.00038657998],"category_scores_gemma":[0.0002147028,0.00030379317,0.00016261195,0.0002987075,0.000031665295,0.0008462252,0.00020377566,0.00023792892,0.0013372398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011621206,0.000025676976,0.007813679,0.000039936443,0.00004588887,0.0000021079384,0.00010486606,0.0017424773,0.000059057693,0.014874893,0.9737787,0.0015010716],"study_design_scores_gemma":[0.001231959,0.0000071973313,0.0011817248,0.0000061688106,0.000025139063,9.722629e-7,0.0002709524,0.0013628964,0.00001269585,0.0011871161,0.9943345,0.0003786776],"about_ca_topic_score_codex":0.8404554,"about_ca_topic_score_gemma":0.15164001,"teacher_disagreement_score":0.6888154,"about_ca_system_score_codex":0.00085649185,"about_ca_system_score_gemma":0.00026030914,"threshold_uncertainty_score":0.9999414},"labels":[],"label_agreement":null},{"id":"W4249590968","doi":"10.2165/00151234-200504830-00014","title":"Infliximab worth it for ankylosing spondylitis in Canada . . .","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ankylosing spondylitis; Infliximab; Medicine; Spondylitis; Internal medicine; Tumor necrosis factor alpha","score_opus":0.0706255941152727,"score_gpt":0.4626623484717373,"score_spread":0.3920367543564646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249590968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8496433,0.0004603977,0.00008725164,0.14105481,0.0023389056,0.0020721494,0.00094166776,0.000061294835,0.0033402152],"genre_scores_gemma":[0.8376679,0.0005792439,0.0012274276,0.15552688,0.001980808,0.00026074983,0.00019927611,0.000073281444,0.002484442],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970283,0.00018342321,0.0012266869,0.000396879,0.00011225903,0.0010524733],"domain_scores_gemma":[0.9980083,0.0009592288,0.00033593093,0.00027444013,0.00006532605,0.0003567504],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005168775,0.000271414,0.00057214394,0.00015679187,0.00032586668,0.000012769258,0.00028690023,0.000126244,0.0016725525],"category_scores_gemma":[0.00009130981,0.00028079117,0.00011382411,0.0001240743,0.000017381139,0.00027200818,0.000092334514,0.00066374964,0.00016745788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012859998,0.000024572095,0.8370114,0.0001891079,0.00001762853,0.0000042275865,0.0009625917,0.00017529992,0.0000029192613,0.00027787767,0.14071533,0.020490471],"study_design_scores_gemma":[0.0036175582,0.000010081074,0.04449183,0.000037949114,0.000022054774,8.4116573e-7,0.0018301134,0.0024239165,0.000011709561,0.000074300486,0.9471674,0.00031226606],"about_ca_topic_score_codex":0.7783036,"about_ca_topic_score_gemma":0.98562855,"teacher_disagreement_score":0.80645204,"about_ca_system_score_codex":0.003033637,"about_ca_system_score_gemma":0.0042229476,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W4249731256","doi":"10.1007/bf03276389","title":"Rx to non-Rx status switch recommended for emergency OC in Canada","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Medicine; Medical emergency; Public health; Nursing","score_opus":0.028153726463321142,"score_gpt":0.34392676331545036,"score_spread":0.3157730368521292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249731256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717995,0.00010588552,0.00012483147,0.016493624,0.002662086,0.0020218957,0.00016091655,0.000039981285,0.006591276],"genre_scores_gemma":[0.96072096,0.00034252604,0.003982026,0.032290515,0.00015111476,0.00027100783,0.000064278254,0.00012219787,0.0020553567],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973089,0.00004462439,0.0009362047,0.0005729671,0.00013276977,0.0010045404],"domain_scores_gemma":[0.99846524,0.0001604388,0.00018139159,0.0004655856,0.00007160903,0.0006557244],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027374644,0.000382442,0.0009136296,0.00022126298,0.00008551242,0.00001856978,0.00021366401,0.00007019297,0.002537865],"category_scores_gemma":[0.00014559712,0.00039867067,0.00021150419,0.00021274228,0.000007847393,0.00013159377,0.000061697036,0.00027326256,0.00013622882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019340748,0.00024261151,0.77499586,0.00011159738,0.00026143965,0.000013171709,0.00048159627,0.00017343758,0.0022068562,0.00015693172,0.21184024,0.009322821],"study_design_scores_gemma":[0.011552952,0.0002896549,0.20843185,0.00003642763,0.00030274142,0.00002174614,0.0009644167,0.0009056991,0.011897129,0.00042150888,0.7640462,0.0011296585],"about_ca_topic_score_codex":0.67798185,"about_ca_topic_score_gemma":0.91152203,"teacher_disagreement_score":0.566564,"about_ca_system_score_codex":0.0030360476,"about_ca_system_score_gemma":0.001855167,"threshold_uncertainty_score":0.9998465},"labels":[],"label_agreement":null},{"id":"W4249836732","doi":"10.1007/s40274-013-0696-8","title":"Quebec's decision to cap price of PPIs \"misguided\"","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Economics; Law and economics; Public health; Medicine","score_opus":0.21739077562156997,"score_gpt":0.47571594499884484,"score_spread":0.2583251693772749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249836732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8889152,0.00090641534,0.006723896,0.0882471,0.002350482,0.0023345072,0.00033364168,0.00011840992,0.010070395],"genre_scores_gemma":[0.75044376,0.0004302809,0.03223724,0.20560552,0.000783405,0.0007146988,0.00006042854,0.00020724199,0.009517445],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99117494,0.00018236977,0.006752351,0.00097373093,0.00012019124,0.0007964432],"domain_scores_gemma":[0.993469,0.0018572345,0.002771191,0.0010697352,0.00015315371,0.00067966955],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005603177,0.0004555192,0.0020005135,0.00072514045,0.00016388086,0.00018497152,0.00093217246,0.00018712481,0.006840914],"category_scores_gemma":[0.0020193518,0.0005570721,0.00040828978,0.00026434226,0.0000631886,0.0012172195,0.00024741836,0.00025493678,0.024973474],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000438794,0.0002668612,0.19715467,0.00027725726,0.0003304652,0.0000012911468,0.0023345845,0.0018626178,0.00016700495,0.05557263,0.7361913,0.0057974705],"study_design_scores_gemma":[0.0036725248,0.0001260841,0.2253632,0.0000917943,0.00003618485,0.000008326322,0.0011791532,0.0072600814,0.00046142412,0.025582772,0.7346618,0.0015566538],"about_ca_topic_score_codex":0.05899775,"about_ca_topic_score_gemma":0.003669344,"teacher_disagreement_score":0.13847141,"about_ca_system_score_codex":0.0010834966,"about_ca_system_score_gemma":0.00024773928,"threshold_uncertainty_score":0.9996881},"labels":[],"label_agreement":null},{"id":"W4249843933","doi":"10.2165/00151234-201106410-00011","title":"Antibacterial stewardship programme saves cost in Canada","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Stewardship (theology); Business; Public health; Medicine; Political science; Nursing; Law","score_opus":0.034024783555338216,"score_gpt":0.2732441944442627,"score_spread":0.23921941088892446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249843933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150306,0.00044214705,0.000008550148,0.0007287967,0.00296293,0.00042705113,0.000070080474,0.000037111422,0.0038202794],"genre_scores_gemma":[0.99520475,0.00023542339,0.00011349769,0.0030971982,0.0000453089,0.000012845369,0.000046573354,0.00002534881,0.0012190727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984422,0.00009221076,0.000498272,0.0003319935,0.000019520392,0.00061580294],"domain_scores_gemma":[0.999435,0.000077884935,0.00016841269,0.00024300287,0.00001708261,0.00005858394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014299966,0.0002364365,0.00045267073,0.00007458338,0.00007212643,0.000015878806,0.0003439176,0.000103395374,0.0014778648],"category_scores_gemma":[0.00001706762,0.00020933441,0.0000913083,0.00005703342,0.000074301366,0.0001192773,0.0000817164,0.00025914295,0.00034023228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003435558,0.00018457156,0.96210605,0.000035788984,0.0002773004,0.00004472866,0.0006110457,0.000002711427,0.012921176,0.0004927543,0.0091637345,0.013816587],"study_design_scores_gemma":[0.0068033957,0.00007150688,0.5805913,0.0000374209,0.000097084834,0.000034120116,0.0013197529,0.000011831504,0.08987696,0.00014649781,0.32015136,0.0008587671],"about_ca_topic_score_codex":0.7884208,"about_ca_topic_score_gemma":0.9061642,"teacher_disagreement_score":0.38151476,"about_ca_system_score_codex":0.00031965578,"about_ca_system_score_gemma":0.00067658635,"threshold_uncertainty_score":0.99943495},"labels":[],"label_agreement":null},{"id":"W4249967566","doi":"10.1007/s40274-020-6514-1","title":"Healthcare administration expenditure greater in USA than Canada","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health administration; Quality of Life Research; Health care; Administration (probate law); Health economics; Public health; Public expenditure; Business; Public economics; Public administration; Public finance; Economics; Political science; Medicine; Economic growth; Nursing; Law","score_opus":0.07905782130683284,"score_gpt":0.33323051698200024,"score_spread":0.2541726956751674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249967566","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41467342,0.00044351202,0.00018082303,0.56845576,0.0013397698,0.00072457374,0.00057174085,0.000037987273,0.013572424],"genre_scores_gemma":[0.8720235,0.00016418632,0.00015469486,0.12666465,0.00025925582,0.000063931504,0.00004229984,0.00003054444,0.00059690804],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977957,0.00003513818,0.0010126701,0.00058630906,0.000039737854,0.0005304264],"domain_scores_gemma":[0.9989526,0.000042175834,0.00032883498,0.00026924128,0.000011227522,0.00039589003],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020565237,0.00026475586,0.0005895757,0.00013350569,0.000078788245,0.000071014605,0.00034338815,0.00008622538,0.0010234766],"category_scores_gemma":[0.000034369496,0.00031644665,0.00011157519,0.00012163983,0.000015045733,0.00027307527,0.000070433445,0.00029353995,0.0007508531],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008115663,0.000054225453,0.8572086,0.0001959191,0.00009024306,0.000064128784,0.0014946025,0.0002491862,0.0000032845753,0.09002667,0.048233315,0.0022986438],"study_design_scores_gemma":[0.0015743892,0.000078633944,0.120187946,0.0000081199105,0.000006954226,0.0000032181056,0.00033335012,0.0018431885,0.00012977302,0.0016331953,0.8736218,0.0005794267],"about_ca_topic_score_codex":0.7168659,"about_ca_topic_score_gemma":0.8248032,"teacher_disagreement_score":0.8253885,"about_ca_system_score_codex":0.0005619442,"about_ca_system_score_gemma":0.00027320502,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W4250440661","doi":"10.1007/s40274-017-4035-3","title":"High-risk screening for lung cancer cost effective in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Lung cancer; Public health; Health economics; Business; Actuarial science; Medicine; Risk analysis (engineering); Environmental health; Oncology; Nursing","score_opus":0.0202402612847341,"score_gpt":0.37652684159130384,"score_spread":0.35628658030656973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250440661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739612,0.00073085126,0.00018143703,0.018621037,0.0017432345,0.0038626937,0.0005286785,0.000019570212,0.00035132418],"genre_scores_gemma":[0.9869977,0.0013301807,0.000803589,0.007259194,0.00030429286,0.00299783,0.000033107804,0.00004576287,0.00022829356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878705,0.00002288848,0.00032549104,0.0003934877,0.00007901789,0.0003920886],"domain_scores_gemma":[0.99870276,0.00031604097,0.00032245184,0.00041670803,0.000039061833,0.00020298529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013960495,0.0002412172,0.0006213299,0.00006020855,0.00022636291,0.000060380822,0.00019099572,0.00003853987,0.0001459837],"category_scores_gemma":[0.000053396485,0.00021097212,0.00015021427,0.000019480303,0.000022018174,0.00015946849,0.000067345325,0.00017648071,0.000004023995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021705715,0.000048490543,0.8939745,0.00006955392,0.00055409514,0.000019405223,0.000047715468,0.00077092554,0.000010892798,0.00004143043,0.013311201,0.09093474],"study_design_scores_gemma":[0.013693804,0.00004620835,0.94918436,0.000101360216,0.00061264896,0.0000019490692,0.00003737698,0.0075766523,0.0024731967,0.000022113643,0.02599491,0.0002554035],"about_ca_topic_score_codex":0.97324187,"about_ca_topic_score_gemma":0.9739589,"teacher_disagreement_score":0.09067933,"about_ca_system_score_codex":0.0035076025,"about_ca_system_score_gemma":0.0007503132,"threshold_uncertainty_score":0.91722584},"labels":[],"label_agreement":null},{"id":"W4250489109","doi":"10.1007/s40274-012-0033-7","title":"A report released by the Canadian Diabetes Association (CDA) recommends that Canada's drug review process be enhanced to ensure wider drug access.","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Quality of Life Research; Process (computing); Association (psychology); Public health; Business; Environmental health; Medicine; Computer science; Pharmacology; Psychology; Nursing","score_opus":0.048734976936854205,"score_gpt":0.43756325615396463,"score_spread":0.38882827921711044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250489109","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17212407,0.005262653,0.0000030900449,0.79053843,0.0054840897,0.003235721,0.00061148475,0.0001251988,0.022615237],"genre_scores_gemma":[0.30914658,0.0023604904,0.000036531877,0.67190754,0.0004919142,0.0010441348,0.0003533955,0.000086460714,0.014572918],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99423504,0.00084741035,0.0016125761,0.00060896995,0.0005091214,0.0021869019],"domain_scores_gemma":[0.99390274,0.0019842198,0.0014410912,0.00083267124,0.00032371088,0.0015155404],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036751514,0.0005420195,0.0011884095,0.00015264339,0.0017187318,0.000080768834,0.0010371188,0.00019616021,0.0021227095],"category_scores_gemma":[0.00093249977,0.00043435002,0.00022598573,0.00032411955,0.00002303395,0.0007895708,0.00023616801,0.0013720855,0.00018771604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000006956789,0.0000151014665,0.41654015,0.00040623738,0.00009334333,0.0000018719134,0.0005632188,0.000001142007,0.0000058501582,0.0000073253777,0.58082163,0.0015371785],"study_design_scores_gemma":[0.00067622046,0.0000049136243,0.057587974,0.00014978187,0.00018644493,0.000001529261,0.00032255953,0.0000052038554,0.00036324462,0.000033811953,0.94017047,0.00049784646],"about_ca_topic_score_codex":0.9217569,"about_ca_topic_score_gemma":0.9913386,"teacher_disagreement_score":0.35934883,"about_ca_system_score_codex":0.010267246,"about_ca_system_score_gemma":0.009687565,"threshold_uncertainty_score":0.9998108},"labels":[],"label_agreement":null},{"id":"W4250745188","doi":"10.1007/bf03266922","title":"Generics deal for pharmaceutical industry in Quebec?","year":2000,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Pharmaceutical industry; Public health; Medicine; Pharmacology","score_opus":0.08134391400180845,"score_gpt":0.3750161646133117,"score_spread":0.29367225061150326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250745188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.885884,0.001571468,0.00028636807,0.051483005,0.0013618028,0.0013280886,0.0011706031,0.00014308885,0.0567716],"genre_scores_gemma":[0.7654191,0.0032231084,0.0027616813,0.21118554,0.0013044055,0.00059163786,0.00013917632,0.00025357492,0.015121771],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960387,0.000036177564,0.0017904076,0.000944923,0.00003502876,0.0011547722],"domain_scores_gemma":[0.99836135,0.00028801538,0.00032473486,0.00045262885,0.000019286645,0.000553966],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00072949997,0.0005052983,0.0011413135,0.0003950515,0.00013628256,0.00021529118,0.0007209897,0.00058130926,0.008758296],"category_scores_gemma":[0.000044694887,0.00063087215,0.00046147255,0.00022485387,0.000106790816,0.0006261113,0.000100752804,0.0011590227,0.0026333288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081064407,0.001350383,0.41175357,0.00021178779,0.00084962137,0.000033813398,0.0012177094,0.009199678,0.00018825514,0.22710688,0.16120851,0.18606915],"study_design_scores_gemma":[0.004604417,0.00003017869,0.007058868,0.000005461523,0.000028956885,0.000005775483,0.000031261676,0.026096413,0.0002350475,0.013623022,0.9475074,0.00077323895],"about_ca_topic_score_codex":0.004456807,"about_ca_topic_score_gemma":0.0022605474,"teacher_disagreement_score":0.7862989,"about_ca_system_score_codex":0.0005640064,"about_ca_system_score_gemma":0.00012439216,"threshold_uncertainty_score":0.99961424},"labels":[],"label_agreement":null},{"id":"W4250881677","doi":"10.2165/00151234-200604990-00023","title":"Canadian generic market grows, but new drug access lags","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Drug; Business; Economics; Public health; Medicine; Pharmacology","score_opus":0.04633601836258157,"score_gpt":0.31835120293496816,"score_spread":0.2720151845723866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250881677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4629406,0.003997582,0.0002920209,0.1071378,0.004923614,0.00105416,0.00240604,0.00025255614,0.4169956],"genre_scores_gemma":[0.81657803,0.002000114,0.0008967309,0.117828265,0.002422054,0.00009768167,0.00019114104,0.00024502733,0.05974094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583143,0.000036444355,0.0016723061,0.0010378539,0.000042749016,0.0013792433],"domain_scores_gemma":[0.9972529,0.00015402399,0.00062337896,0.0007104153,0.000027127899,0.0012321944],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00058314664,0.00061326456,0.0011325856,0.0007650822,0.00027546065,0.0006746858,0.0014484195,0.00018147031,0.0101796435],"category_scores_gemma":[0.000039288407,0.00076692965,0.0005069676,0.0002737073,0.000070380425,0.0010654583,0.00028224709,0.0004527771,0.0044510053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002490325,0.000072241615,0.17572305,0.000023161081,0.00017995159,0.0000143819725,0.00006253165,0.00055579835,0.000019581394,0.061773386,0.7592892,0.002261795],"study_design_scores_gemma":[0.001837082,0.0000092681485,0.032578133,0.000003571653,0.000037453025,0.000010684317,0.000014210701,0.005413193,0.0002319699,0.04948328,0.9094504,0.0009307201],"about_ca_topic_score_codex":0.57540125,"about_ca_topic_score_gemma":0.17827682,"teacher_disagreement_score":0.39712444,"about_ca_system_score_codex":0.0011258756,"about_ca_system_score_gemma":0.00047176747,"threshold_uncertainty_score":0.99947816},"labels":[],"label_agreement":null},{"id":"W4251049664","doi":"10.1007/bf03276210","title":"Disparities in diabetes care delivery in Canada and the US","year":2003,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Diabetes mellitus; Public health; Health economics; Medicine; Environmental health; Gerontology; Nursing","score_opus":0.008480071834728048,"score_gpt":0.2586075133668157,"score_spread":0.25012744153208766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251049664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879423,0.0011835543,1.3570937e-7,0.0058559054,0.0004804944,0.00035818966,0.0000055797477,0.000006429434,0.0041674147],"genre_scores_gemma":[0.9809568,0.00050228107,0.00003291072,0.018181467,0.000027025733,0.000053563555,0.0000129453565,0.000011848294,0.00022117973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924433,0.000049723025,0.00025089318,0.00015748908,0.000048535534,0.00024902774],"domain_scores_gemma":[0.9995799,0.00016407004,0.00005106448,0.00013204783,0.000011472693,0.000061414066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016459479,0.00011759634,0.00028525866,0.000087960216,0.000027861597,0.000028473904,0.00006918247,0.000016925334,0.00007383174],"category_scores_gemma":[0.000038673956,0.00009162311,0.00003522148,0.000061192964,0.000034336797,0.0001070122,0.000028246035,0.00012397706,0.00001304016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020015927,0.000014719418,0.993816,0.0000587832,0.000028559609,0.0000020370533,0.00024699967,0.00007377119,0.0000051527227,0.0003936569,0.0026161256,0.0027241586],"study_design_scores_gemma":[0.004448531,0.000007125611,0.9649364,0.000017933853,0.00006150459,3.7178324e-7,0.001322841,0.00059813634,0.00018252607,0.00019712653,0.0280891,0.00013839897],"about_ca_topic_score_codex":0.6340987,"about_ca_topic_score_gemma":0.8618176,"teacher_disagreement_score":0.22771892,"about_ca_system_score_codex":0.00044181614,"about_ca_system_score_gemma":0.000277392,"threshold_uncertainty_score":0.3736282},"labels":[],"label_agreement":null},{"id":"W4252437751","doi":"10.1007/bf03278672","title":"Inadequate thromboprophylaxis common in Canada","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Public health; Medicine","score_opus":0.025543460248884455,"score_gpt":0.2975303013503977,"score_spread":0.2719868411015133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252437751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538611,0.00039387532,0.0000033612946,0.02455657,0.00077092694,0.0006466932,0.000016277907,0.00004075179,0.019710407],"genre_scores_gemma":[0.954235,0.0013621484,0.0001223518,0.043317422,0.00009062086,0.000060803846,0.000012445984,0.000041609113,0.0007575576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836963,0.000035068526,0.0005802188,0.0003668881,0.00015084933,0.0004973266],"domain_scores_gemma":[0.99914014,0.00008101068,0.00013265725,0.0003943941,0.00001782566,0.00023396628],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011352488,0.00026385495,0.00086500146,0.00015240771,0.00005720906,0.00002843634,0.0002089362,0.000040740382,0.0026930019],"category_scores_gemma":[0.000014604867,0.00025111416,0.00012424035,0.00013004194,0.000022590722,0.00013126104,0.00010755997,0.0002655566,0.00034406138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003132056,0.0006592096,0.73702085,0.00013908741,0.00033333772,0.00026593322,0.0004020499,0.00043063945,0.00018925779,0.00070451194,0.17599213,0.08383166],"study_design_scores_gemma":[0.0051716384,0.00013021819,0.74852246,0.000040738636,0.0001839775,0.000017473765,0.0003662672,0.0072620544,0.0010145984,0.00022416342,0.23646706,0.00059937924],"about_ca_topic_score_codex":0.87914217,"about_ca_topic_score_gemma":0.90382296,"teacher_disagreement_score":0.08323228,"about_ca_system_score_codex":0.0013192303,"about_ca_system_score_gemma":0.00017659087,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W4252660209","doi":"10.1007/bf03269644","title":"NSAID-related GI disorders costly in Canada's elderly","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.007799019978490119,"score_gpt":0.28141762316589164,"score_spread":0.2736186031874015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252660209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97836274,0.00032524712,0.0000069666994,0.01064696,0.0016103482,0.00072337326,0.000013245715,0.00006439741,0.008246739],"genre_scores_gemma":[0.98549235,0.00085638463,0.000051591367,0.0119911935,0.00013169809,0.000052381783,0.000034099427,0.0000622046,0.0013280952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806845,0.00006843452,0.0006826595,0.00039304,0.00016046954,0.0006269568],"domain_scores_gemma":[0.99888337,0.00020617133,0.00016431275,0.00033018118,0.000024621855,0.00039135487],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025299957,0.00032878848,0.0006708312,0.00019895553,0.000063092724,0.000020549478,0.00018734047,0.00009514157,0.0010175187],"category_scores_gemma":[0.000055547975,0.00031342622,0.00016531203,0.00017301021,0.000033367258,0.0001523506,0.000044509372,0.00044588832,0.00024400324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001817389,0.00008413663,0.94437003,0.000042462812,0.00012701195,0.00022012896,0.00014139188,0.000247396,0.00031226684,0.000068884736,0.01240948,0.041795053],"study_design_scores_gemma":[0.014655617,0.00017224207,0.55457175,0.000057317782,0.00018715304,0.00008931949,0.00030556164,0.0060027232,0.0008991869,0.00022169776,0.42201945,0.0008179871],"about_ca_topic_score_codex":0.61706454,"about_ca_topic_score_gemma":0.8836873,"teacher_disagreement_score":0.40960997,"about_ca_system_score_codex":0.0011783622,"about_ca_system_score_gemma":0.001138968,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W4253046517","doi":"10.1007/s40274-016-2925-4","title":"ASCO endorses Cancer Care Ontario treatment guidelines","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Medicine; Public health; Cancer; Family medicine; Nursing; Internal medicine","score_opus":0.2915147588622064,"score_gpt":0.5500505289812848,"score_spread":0.2585357701190784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253046517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8790273,0.00058498484,0.00015762525,0.11517022,0.0019546074,0.00096980546,0.00016174042,0.00012343003,0.0018502746],"genre_scores_gemma":[0.8645529,0.0064860242,0.007878542,0.09314945,0.0021794958,0.00048583563,0.00016427966,0.0001487152,0.024954714],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997423,0.00005036625,0.0014503032,0.00052300206,0.00015461493,0.00039870315],"domain_scores_gemma":[0.9978566,0.00069301785,0.000413326,0.00045872648,0.0002753551,0.00030295402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020101252,0.00034816767,0.0006541226,0.00011268585,0.00008082423,0.0000357102,0.00015046092,0.000075462616,0.006183044],"category_scores_gemma":[0.00039198934,0.00022147821,0.0003633932,0.00004831245,0.000041263873,0.00036261042,0.00007743499,0.000122642,0.0005625635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028724843,0.00010975096,0.6467002,0.000015807873,0.0004125938,0.000015875254,0.00045157314,0.000022612754,0.0026363884,0.000034238692,0.03148692,0.31782675],"study_design_scores_gemma":[0.011166576,0.00023377729,0.046867613,0.000042222026,0.0007836569,0.000020080683,0.00044487562,0.000037479756,0.007877328,0.000060062226,0.9321426,0.00032372642],"about_ca_topic_score_codex":0.10389879,"about_ca_topic_score_gemma":0.21091253,"teacher_disagreement_score":0.9006557,"about_ca_system_score_codex":0.0024799893,"about_ca_system_score_gemma":0.0010183154,"threshold_uncertainty_score":0.99472547},"labels":[],"label_agreement":null},{"id":"W4253178590","doi":"10.1007/bf03279389","title":"High resource use, costs for type 1 DM in Canada vs US","year":2002,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Resource (disambiguation); Resource use; Business; Economics; Natural resource economics; Public health; Computer science; Medicine; Computer network","score_opus":0.3509024066080205,"score_gpt":0.4395808854166129,"score_spread":0.08867847880859236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253178590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86727685,0.0012111777,0.00021281686,0.120703526,0.0038716649,0.0019749883,0.0015156666,0.00007538408,0.0031579346],"genre_scores_gemma":[0.74639446,0.0006302462,0.0029547005,0.24382612,0.00067389023,0.00033029992,0.00015761188,0.00015844328,0.00487424],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934184,0.00020839587,0.0044941795,0.00089753163,0.000078224075,0.0009032664],"domain_scores_gemma":[0.9945918,0.0024569663,0.0018079325,0.0007012935,0.00005706088,0.0003849579],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0036211275,0.00041199557,0.0016798775,0.0003963624,0.00017755669,0.00016319935,0.0005882999,0.00014259088,0.0017846734],"category_scores_gemma":[0.0015035069,0.00055607647,0.00019635081,0.00020472766,0.00003779973,0.0008243775,0.00009465076,0.000312467,0.0015591249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050078266,0.0000691027,0.4962054,0.000091925096,0.000104569255,0.0000030017302,0.00022309634,0.0027212987,0.0000016715047,0.009162984,0.4909203,0.0004465911],"study_design_scores_gemma":[0.003233139,0.000047414323,0.054208998,0.00002350352,0.000014579197,0.0000043002074,0.00022695838,0.025982086,0.000016670183,0.0010477517,0.9144734,0.0007211766],"about_ca_topic_score_codex":0.79981124,"about_ca_topic_score_gemma":0.759084,"teacher_disagreement_score":0.4419964,"about_ca_system_score_codex":0.00549738,"about_ca_system_score_gemma":0.00044396738,"threshold_uncertainty_score":0.9996891},"labels":[],"label_agreement":null},{"id":"W4253917067","doi":"10.1007/s40274-014-1042-5","title":"Ticagrelor good value for money in ACS in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Value (mathematics); Value for money; Quality of Life Research; Business; Economics; Medicine; Mathematics; Internal medicine; Acute coronary syndrome; Public health; Public economics; Statistics","score_opus":0.011728007418592597,"score_gpt":0.290141817118358,"score_spread":0.2784138096997654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253917067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920817,0.00055189943,0.00015761316,0.0045188395,0.000410262,0.00068607565,0.000032888955,0.000020778625,0.0015399586],"genre_scores_gemma":[0.9795956,0.00038284925,0.00026426528,0.019240353,0.0001419447,0.000081956154,0.000033482193,0.00003817573,0.0002213855],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873704,0.000056751374,0.00042687292,0.00030811515,0.00009560065,0.00037564556],"domain_scores_gemma":[0.99924374,0.00020730909,0.00007006279,0.00027719242,0.000017533192,0.00018414174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028767157,0.00019871508,0.0006345141,0.000104818406,0.000027661323,0.000013557609,0.00014258534,0.000049078524,0.00006346469],"category_scores_gemma":[0.000053339812,0.00018922889,0.0002445685,0.000071371316,0.000015992966,0.000086423184,0.000028979208,0.00015597785,0.000023769673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006023374,0.00017128095,0.92669415,0.0001445651,0.000508683,0.000048949227,0.00013073275,0.0024168852,0.00040518926,0.0014066016,0.0041019176,0.06336869],"study_design_scores_gemma":[0.029464101,0.00011797294,0.4141339,0.0000708218,0.00043484312,0.000035782734,0.0003320659,0.01648569,0.0045776386,0.0007056763,0.5328401,0.00080141664],"about_ca_topic_score_codex":0.2808717,"about_ca_topic_score_gemma":0.390591,"teacher_disagreement_score":0.52873814,"about_ca_system_score_codex":0.0005074575,"about_ca_system_score_gemma":0.0005201279,"threshold_uncertainty_score":0.771653},"labels":[],"label_agreement":null},{"id":"W4253997077","doi":"10.1007/s40274-013-0647-4","title":"Cardiovascular research in Canada: good return on investment","year":2013,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Investment (military); Return on investment; Economics; Health economics; Business; Actuarial science; Public health; Medicine; Political science; Microeconomics; Economic growth; Law","score_opus":0.18665998838135112,"score_gpt":0.4550599772445519,"score_spread":0.26839998886320077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253997077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82373303,0.00074672146,0.0000018675811,0.14296144,0.00045939672,0.0019198968,0.000012331119,0.000022495658,0.030142816],"genre_scores_gemma":[0.8190176,0.0013457006,0.00010925856,0.17780587,0.00027721457,0.00027895017,0.00001711616,0.00004147341,0.0011068201],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960611,0.00030523486,0.00056694896,0.00045148082,0.0008913436,0.0017239316],"domain_scores_gemma":[0.9932516,0.0006593314,0.00004728129,0.00064478896,0.000114863,0.0052821017],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023833134,0.00021172175,0.00069902797,0.00034654717,0.000078545076,0.00003436093,0.0002510789,0.000082914215,0.0008629472],"category_scores_gemma":[0.00243822,0.00016944736,0.00018122175,0.00024323269,0.00006435214,0.00013057553,0.00010497751,0.0012511319,0.0007891961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021227007,0.00031507626,0.22024617,0.00036842856,0.0005244756,0.0004908651,0.00021207833,0.00008596191,0.00031225212,0.000456703,0.60691255,0.1698632],"study_design_scores_gemma":[0.005972806,0.0003287443,0.08828657,0.00010385204,0.000033659624,0.000020946765,0.0003459239,0.0013490781,0.0011936628,0.0003541557,0.90175873,0.00025186242],"about_ca_topic_score_codex":0.91906124,"about_ca_topic_score_gemma":0.39335752,"teacher_disagreement_score":0.5257037,"about_ca_system_score_codex":0.005378568,"about_ca_system_score_gemma":0.017566659,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W4255482650","doi":"10.2165/00151234-201206490-00031","title":"Denosumab available for PMO in Ontario","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Denosumab; Quality of Life Research; Medicine; Business; Public health; Internal medicine; Nursing","score_opus":0.06464038649937859,"score_gpt":0.37620207856215016,"score_spread":0.31156169206277157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255482650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791488,0.0005345645,0.000016935037,0.00374559,0.0011023264,0.0012092605,0.00001727969,0.000043721768,0.014181543],"genre_scores_gemma":[0.9344966,0.00012301638,0.0033289988,0.02460681,0.00013357401,0.000288112,0.000078143676,0.000052930718,0.036891803],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998622,0.000014696342,0.0004294756,0.00022979362,0.000053654843,0.00065037544],"domain_scores_gemma":[0.99913543,0.00011191583,0.00010011876,0.0002271877,0.00001833198,0.00040702854],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020262114,0.00019622126,0.00047720948,0.000119874225,0.000056614725,0.000013410643,0.00007168196,0.00007200627,0.001672582],"category_scores_gemma":[0.000018108429,0.00017837681,0.00014766215,0.00003770101,0.000013575653,0.00023019516,0.000029071856,0.00019799035,0.0013679889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027056594,0.0003646263,0.97087574,0.000040187762,0.00009258784,0.00000351085,0.00030377324,0.0000019671559,0.000040266317,0.00013123514,0.02475906,0.0031164982],"study_design_scores_gemma":[0.009784306,0.00007701974,0.37067404,0.000009964038,0.0001360177,0.000019135594,0.000025106901,0.000079417514,0.0006009626,0.000075843396,0.6183444,0.0001737385],"about_ca_topic_score_codex":0.059956122,"about_ca_topic_score_gemma":0.08395614,"teacher_disagreement_score":0.60020167,"about_ca_system_score_codex":0.000948447,"about_ca_system_score_gemma":0.00034785754,"threshold_uncertainty_score":0.99940956},"labels":[],"label_agreement":null},{"id":"W4255485385","doi":"10.2165/00151234-201206550-00035","title":"Expansion of Canadian insulin pump programme cost saving","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Insulin pump; Economics; Public health; Medicine; Diabetes mellitus; Endocrinology; Nursing; Type 1 diabetes","score_opus":0.04300395360708603,"score_gpt":0.3388789495350784,"score_spread":0.2958749959279924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255485385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791235,0.00053807726,0.000023829569,0.0059066312,0.0010617936,0.0007848248,0.000058489313,0.000043526026,0.012459355],"genre_scores_gemma":[0.9878085,0.00042636422,0.0007557979,0.01017781,0.0002534922,0.00006373932,0.00007034135,0.000035805206,0.00040810957],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982654,0.000029699164,0.0005854052,0.00022335441,0.000121338235,0.00077484123],"domain_scores_gemma":[0.9983728,0.0001103715,0.0001130319,0.00028020667,0.00008672641,0.001036865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022189159,0.00022743893,0.0005716372,0.00038710173,0.000081138045,0.000019153982,0.00013908847,0.000118352276,0.0006248017],"category_scores_gemma":[0.00011418841,0.00020213117,0.00023130488,0.00016034445,0.000058862224,0.00021454862,0.000046198158,0.00023837523,0.00016484589],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030930465,0.00032806987,0.897568,0.00011117925,0.00024267305,0.000013948011,0.00081617694,0.0000063395155,0.003975895,0.0012669385,0.0031298718,0.09223161],"study_design_scores_gemma":[0.013120395,0.00029893836,0.12231631,0.00009666862,0.0006129078,0.00006396373,0.0005927717,0.00064604345,0.0063607423,0.00010850517,0.85511804,0.00066469633],"about_ca_topic_score_codex":0.039090086,"about_ca_topic_score_gemma":0.0053608785,"teacher_disagreement_score":0.8519882,"about_ca_system_score_codex":0.0002156568,"about_ca_system_score_gemma":0.0002718893,"threshold_uncertainty_score":0.9673087},"labels":[],"label_agreement":null},{"id":"W4255805731","doi":"10.1007/bf03269472","title":"Antipsychotic polypharmacy in schizophrenia in Canada","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polypharmacy; Antipsychotic; Quality of Life Research; Schizophrenia (object-oriented programming); Psychiatry; Medicine; Public health; Pharmacology; Nursing","score_opus":0.025288951264691797,"score_gpt":0.3464655573702587,"score_spread":0.3211766061055669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255805731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97678405,0.0006878453,0.0000023494258,0.019538485,0.00047949006,0.0007172294,0.000019433879,0.000029642088,0.0017414847],"genre_scores_gemma":[0.9883809,0.0015997963,0.0005015449,0.008859621,0.00011228141,0.00007192789,0.000027763654,0.00004237557,0.00040380706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978962,0.00006380043,0.00062357436,0.00046809748,0.00020070221,0.0007476229],"domain_scores_gemma":[0.9989094,0.00015567863,0.00008628854,0.0003549167,0.000021619364,0.00047208482],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016746586,0.00030443637,0.00063167623,0.00042687802,0.000037424426,0.000029784978,0.00022272299,0.00004125764,0.0010694086],"category_scores_gemma":[0.000033868997,0.00028039046,0.00012355711,0.0003288073,0.000024559826,0.00017663528,0.00006094565,0.0004638392,0.0002229884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059510237,0.0002534011,0.9538306,0.000019481517,0.00010530896,0.0014102373,0.000032978973,0.00008875683,0.00023014809,0.00009806445,0.0024176985,0.03556233],"study_design_scores_gemma":[0.03142362,0.0000484799,0.9553066,0.00003402379,0.000043278324,0.00014196202,0.00008862566,0.0023909113,0.00069967686,0.00023395513,0.009282191,0.00030670798],"about_ca_topic_score_codex":0.8209665,"about_ca_topic_score_gemma":0.96322113,"teacher_disagreement_score":0.14225464,"about_ca_system_score_codex":0.0019757063,"about_ca_system_score_gemma":0.0023404136,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W4256330601","doi":"10.1007/bf03280626","title":"Canada to respect `Cipro' patent","year":2001,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Business; Mathematics; Medicine; Public health","score_opus":0.14484623391866427,"score_gpt":0.2821749050451156,"score_spread":0.13732867112645133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256330601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8655216,0.00005228511,0.00007233776,0.035121262,0.0027705026,0.000566597,0.0000134736665,0.00012052204,0.09576142],"genre_scores_gemma":[0.79104584,0.00003462201,0.000043145308,0.20093784,0.00094596815,0.00003152549,0.000019540163,0.000042907308,0.006898627],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985278,0.000010701146,0.00041893538,0.00038270516,0.00014661853,0.0005132271],"domain_scores_gemma":[0.99940103,0.00006898259,0.00012913988,0.00026816514,0.000074248084,0.000058409874],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018392388,0.00027197023,0.000317592,0.00017470987,0.0001979243,0.00023827112,0.00046236196,0.000038506994,0.0033866663],"category_scores_gemma":[0.00009574504,0.00023442943,0.000112005066,0.00020657739,0.000012573613,0.0005226678,0.00023200561,0.0001703529,0.0033395402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033032344,0.00009166782,0.15598945,0.000045639517,0.00013833378,0.000087321554,0.000072802075,0.0012218356,0.0004158806,0.0014332574,0.8222144,0.017959082],"study_design_scores_gemma":[0.00068960123,0.000007296675,0.0066242847,0.000007613135,0.000034051227,0.0000034263414,0.000056343502,0.0023793848,0.00023981732,0.00021350713,0.98937744,0.00036722625],"about_ca_topic_score_codex":0.74263316,"about_ca_topic_score_gemma":0.57516855,"teacher_disagreement_score":0.16746461,"about_ca_system_score_codex":0.00023323175,"about_ca_system_score_gemma":0.00013241296,"threshold_uncertainty_score":0.9975244},"labels":[],"label_agreement":null},{"id":"W4256444138","doi":"10.2165/00151234-200504800-00031","title":"Expanding newborn screening warranted in Canada","year":2005,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Mental Health and Psychiatry","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.038682998840174974,"score_gpt":0.3198671131999052,"score_spread":0.28118411435973023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256444138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9201447,0.00044398993,0.000035910383,0.020889303,0.003228616,0.00035326296,0.00009498025,0.000054176522,0.05475509],"genre_scores_gemma":[0.9442437,0.00008296118,0.0007675742,0.051397383,0.0010326877,0.000024516348,0.000028023269,0.000032297175,0.002390799],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986075,0.000033709686,0.0005472838,0.00024217063,0.00008351941,0.0004858033],"domain_scores_gemma":[0.9994107,0.00008918645,0.00013007889,0.00014908424,0.000010896985,0.00021008687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013416496,0.00019902945,0.00030509126,0.00011262923,0.0002122466,0.00007154562,0.00020638532,0.000021046888,0.0049879206],"category_scores_gemma":[0.00000352809,0.000194071,0.00007302116,0.000023430242,0.000020807867,0.00030465168,0.00003462927,0.00022198011,0.00014572169],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022566578,0.0001280647,0.4431388,0.00012742916,0.00011767112,0.000018011271,0.012820217,0.0009225656,0.000044640605,0.008528936,0.12830213,0.40562585],"study_design_scores_gemma":[0.0016901705,0.000009782281,0.00400734,0.000016557879,0.000011560743,0.000002089139,0.0034839248,0.002328131,0.00006882222,0.00008705045,0.98801804,0.00027650973],"about_ca_topic_score_codex":0.8802218,"about_ca_topic_score_gemma":0.99336165,"teacher_disagreement_score":0.85971594,"about_ca_system_score_codex":0.00052305346,"about_ca_system_score_gemma":0.00032111985,"threshold_uncertainty_score":0.9959217},"labels":[],"label_agreement":null},{"id":"W4256608425","doi":"10.2165/00151234-201206500-00002","title":"Canadian guidelines for AF published","year":2012,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Public health; Medicine; Nursing","score_opus":0.1577735194765171,"score_gpt":0.4458158944863247,"score_spread":0.28804237500980756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256608425","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24490437,0.0010056166,0.0009010642,0.70642215,0.008525923,0.003264536,0.00013913798,0.0003129893,0.034524232],"genre_scores_gemma":[0.73466736,0.00029275127,0.017950151,0.18679167,0.010157851,0.00007334862,0.00042858336,0.00015298506,0.049485315],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838686,0.000016937414,0.00061930565,0.00024623857,0.000091549206,0.00063909055],"domain_scores_gemma":[0.99851936,0.0001514804,0.00015204726,0.0003030689,0.00016763512,0.00070638716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005071782,0.00023641602,0.0004982454,0.00031090784,0.00012348108,0.000086437154,0.00015319229,0.00008033055,0.001530397],"category_scores_gemma":[0.00040518327,0.00020708257,0.0003793456,0.00009633567,0.000015362952,0.00059383665,0.000047959053,0.000093551345,0.00039023056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005088697,0.0000057668526,0.6613125,0.000027651735,0.00017909467,6.286521e-7,0.000053244847,0.000019384686,0.00008476442,0.0021555352,0.32899567,0.0071148393],"study_design_scores_gemma":[0.0024949056,0.000017023855,0.05505612,0.000003998627,0.00022677938,0.000003970123,0.000077847406,0.0006208811,0.00025946283,0.00018715467,0.9408245,0.00022734297],"about_ca_topic_score_codex":0.012150356,"about_ca_topic_score_gemma":0.007558729,"teacher_disagreement_score":0.6118288,"about_ca_system_score_codex":0.00035860352,"about_ca_system_score_gemma":0.00019739699,"threshold_uncertainty_score":0.9993823},"labels":[],"label_agreement":null}]}